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Abstract 
Amorphous pharmaceuticals have gained widespread importance due to their 
advantageous increase in solubility and dissolution rate. However, a major challenge with 
this approach is the high risk of physicochemical instability in comparison to its 
crystalline counterparts. The goal of my research was to investigate the correlations 
between molecular mobility and physical stability in model amorphous systems (both 
drug substance and solid dispersions), specifically in the glassy state. This will potentially 
enable development of effective strategies to stabilize amorphous pharmaceuticals. Use 
of time-temperature, time-aging and time-concentration superposition principle enabled 
comprehensive characterization of structural relaxation behavior in the glassy state. This 
was followed by the investigation of correlation between crystallization behavior and 
different mobility modes in glassy celecoxib and indomethacin. Structural relaxation time 
correlated well with characteristic crystallization time in the supercooled state. On the 
other hand, a stronger correlation was observed between the Johari-Goldstein relaxation 
time and physical instability in the glassy state but not with structural relaxation time. 
Effect of polymer additive and polymer concentration on the structural relaxation 
behavior in nifedipine dispersions was investigated. We found that stronger drug-polymer 
interactions enhanced physical stability by reducing the molecular mobility. With an 
increase in polymer concentration, the relaxation times were longer indicating a decrease 
in molecular mobility. The effect of sorbed water on molecular mobility and physical 
stability in a model amorphous drug and dispersion was also evaluated. Sorbed water, in 
a concentration dependent manner, increased mobility and accelerated crystallization - 
attributable to the plasticization effect of water. The extent of coupling between 
molecular mobility and crystallization time (defined as time for 2.5% crystallization) was 
found to be unaffected in the range of water content studied ( < 2% w/w). Based on this 
finding, we have proposed the use of “water sorption” as an accelerated stability 
approach to predict crystallization in slow crystallizing systems.   
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1.1 Introduction 
 
A large fraction of the new drugs under development are characterized by poor aqueous 
solubility1. As a result, their absorption following oral administration can be a challenge. 
Drug amorphization is an effective and popular strategy to enhance solubility2. However, 
a major challenge with this approach is the risk of crystallization due to physical 
instability. This can negate the bioavailability advantage brought about by the solubility 
enhancement. An added complication with amorphous materials is that the thermal 
history imparted by the preparation method and storage conditions can impact the 
pharmaceutical properties of interest such as vapor sorption and crystallization 
propensity. The overall goal of the current research is to investigate the role of molecular 
mobility on the physical stability of amorphous pharmaceuticals in single (drug alone) 
and multi-component systems (solid dispersion).  
1.2 Motivation 
 
The amorphous form of a compound is inherently unstable due to its higher free energy 
than its crystalline counterpart. This instability could be chemical i.e. chemical 
degradation as well as physical i.e. crystallization to the stable low energy form. 
Excellent analytical tools are available to characterize chemical instability especially in 
the solution state. Studying degradation kinetics at elevated temperatures and 
extrapolating to room temperature is an approach classically used to predict chemical 
degradation. However, such an approach cannot be used for physical stability 
(crystallization) prediction. The two steps involved in crystallization i.e. nucleation and 
crystal growth exhibit different temperature dependence. Additionally, water sorbed 
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either during processing or storage can have a dramatic influence on the physical stability 
of these materials. Therefore, predicting physical stability under relevant storage 
conditions is not straightforward. This poses a major obstacle in the widespread use of 
amorphous pharmaceuticals.  
Molecular mobility has been extensively investigated in light of its possible role in 
governing physical stability3,4,5,6,7. Molecular mobility comprises both global and local 
motions. Global motion is cooperative in nature and is responsible for bringing about the 
glass transition. It is also referred as α- or structural relaxation. On the other hand, local 
motions (or secondary relaxations) are non-cooperative in nature and arise from either a 
part or an entire molecule8,9. In several compounds, structural relaxation time has been 
linked to physical instability in the supercooled state (T > Tg)
10,11,12. Interestingly, β-
relaxation (also referred to as Johari-Goldstein relaxation13) has been implicated in 
physical instability of glasses (T < Tg)
14,15,16,17. We believe that any approach used to 
build predictive models should consider the influence of both global and local motions.  
Dielectric spectroscopy (DES) allows direct measurement of molecular motions 
associated with dipole reorientation in the frequency range of 10-6 to 1012 Hz18. Time 
domain dielectric techniques such as isothermal depolarization and thermally stimulated 
current19,20 have been employed to characterize molecular motions in glassy 
pharmaceuticals. Using DES, different relaxations can be studied simultaneously and 
correlation between a specific mobility and stability can be established.  
In the present work, we have extensively used DES to comprehensively characterize the 
molecular motions in model amorphous systems. In Chapter 2, nifedipine, an 
antihypertensive, was used as a model compound. The time-aging time or time-
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temperature superposition principle was used as an approach to calculate the time or 
temperature dependence of global motions respectively in glassy nifedipine. This enabled 
the comprehensive characterization of structural relaxation. In Chapter 3, we investigated 
the correlations between crystallization time (time for 2.5% crystallization) and different 
relaxations (both local and global) in glassy celecoxib and indomethacin. This not only 
enabled the identification of a specific mobility mode responsible for the observed 
instability but allowed the development of models to predict crystallization at 
temperatures below Tg.     
In an effort to stabilize amorphous compounds, they are fabricated as solid dispersions 
which are molecular drug – polymer mixtures. Different mechanisms such as hydrogen-
bonding, physical barrier or anti-plasticization effect have been proposed to explain the 
stabilization mechanism of polymer21,22,23. However, a comprehensive understanding is 
still lacking. Very few studies have investigated the stabilization mechanism in the glassy 
state. In Chapter 4, in an effort to explain the observed effect of polymer on physical 
stability, we have studied the influence of polymer additives and their concentration on 
relaxation behavior in glassy dispersions.  
Amorphous systems are typically characterized by a pronounced tendency to sorb water. 
Water, by increasing the free volume24, causes plasticization leading to an increase in 
mobility. This can potentially increase the risk of physicochemical instability in 
amorphous materials25,26,27. One approach to minimize water uptake by amorphous 
materials is  to tightly control the water vapor pressure in the atmosphere. However, 
during the manufacture and storage of amorphous pharmaceuticals, there are practical 
limits to the extent to which the ambient water vapor pressure can be reduced. It is 
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therefore valuable to investigate the role of water on the physical stability of amorphous 
pharmaceuticals. In Chapter 5, we systematically vary the water content in a model 
amorphous system to determine the effects on (i) molecular mobility, and (ii) 
crystallization behavior. Based on these results, in Chapter 6, we are proposing the use of 
water sorption as an accelerated stability approach to predict crystallization in amorphous 
solid dispersions.       
1.3 Isothermal crystallization kinetics 
 
Devitrification involves two steps: formation of stable nuclei followed by growth of these 
nuclei into crystals. Nucleation can be of two types – homogenous and heterogeneous. 
Homogenous nucleation occurs spontaneously whereas nucleation taking place under the 
influence of an external stimulus such as impurities or seeds is termed heterogeneous 
nucleation28. The rate of homogenous nucleation, J, i.e. the number of nuclei formed per 
unit time per unit volume is described by the classical nucleation theory28,29: 
                                                                     (1.1) 
where A is a pre-exponential factor, , kB is the Boltzmann constant, T is the temperature 
and ΔG is the change in Gibbs free energy associated with the formation of nuclei of a 
critical size. It is given by 28: 
                                                             (1.2) 
where ΔGs is free energy difference the surface of the particle and the bulk of the particle 
and ΔGv is the excess free energy between a very large particle (r = ∞) and the solute in 
solution. The driving force for nucleation increases as the degree of undercooling 
increases. However, the viscosity of the system increases as the temperature is lowered 
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resulting in reduced molecular mobility and increased kinetic barrier for nucleation. 
Turnbull and Fisher quantified this behavior and derived a modified form of equation 1.1 
28, 30: 
                                                                  (1.3) 
where γ is the interfacial tension between the developing crystalline surface and the 
supersaturated solution, ν is the molecular volume, S is the degree of supersaturation and 
ΔG’ is the kinetic barrier to nucleation. The kinetic barrier is related to the viscosity and 
is the activation energy for molecular motion across the embryo-matrix interface29. 
Nucleation is thermodynamically favored at higher degrees of supercooling and crystal 
growth is favored at lower degrees of supercooling (that is, higher temperatures). The 
growth rate of individual crystals, U, is given by the following relationship 29, 31: 
                                                     )]            (1.4) 
where C and w are constants and w depends on the mechanism of growth and η is 
viscosity of the system and reflects the molecular mobility . As can be seen from 
equations 1.3 and 1.4, the two processes, nucleation and crystal growth show different 
temperature dependences. There is only a very narrow temperature window where the 
two processes i.e. nucleation and crystal growth overlap. However, it has been found 
experimentally that crystallization can occur at temperatures where nucleation is 
predominant. This makes the independent characterization of the two processes 
extremely difficult. Hence, the models used to study the kinetics of crystal growth take 
into account nucleation and crystal growth. The Kolmogorov-Johnson-Mehl-Avrami 
(KJMA) theory is widely used to describe the overall process of crystallization 29, 32: 
                                                                (1.5) 
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where α is the fraction crystallized at time t, k is a constant described by nucleation and 
growth rate constants, to is the induction time and n represents the morphology of growth 
depending on the nucleation mechanism. The following assumptions have been made in 
deriving the above expression: (i) rates of nucleation and growth are time independent, 
(ii) nucleation is homogenous, and (iii) linear steady state growth29. This model has been 
used to describe isothermal crystallization in the area of pharmaceutical research33.  
1.4 Molecular mobility and crystallization 
 
As mentioned before, in equation 3, the overall rate of nucleation can be described by a 
free energy change upon nucleation based on thermodynamic considerations and a 
‘kinetic barrier’ representing the energy required for molecular transport. Furthermore, 
we can incorporate the effect of molecular mobility on crystallization through this 
expression given by Ngai et al 34: 
                                                                        (1.6) 
In this equation, k is the overall rate of crystallization, D (T) is the molecular diffusion 
coefficient which is a function of temperature (can be correlated to the viscosity of the 
system) and f (T) represents the free energy term for nucleation (thermodynamic driving 
force for crystallization). If this relation holds and diffusion is the dominant factor in 
determining the crystallization rate, then crystallization rate at different temperatures can 
be described by the following equation 34a:   
                                                                           (1.7) 
where D1 and D2 are translational diffusion coefficients at temperatures T1 and T2 
respectively and ξ is a factor introduced to compensate for any decoupling between the 
diffusion coefficient and viscosity of the matrix.  
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Molecular mobility is being extensively studied in the field of amorphous 
pharmaceuticals and has been thought to a be a major factor governing the 
physicochemical instability of amorphous pharmaceuticals 33c, 35. Several studies have 
shown a correlation between molecular mobility and physical instability of amorphous 
materials 33b, c, 34a, 36 and higher mobility is often held responsible for the increased 
instability in the amorphous state. Therefore, current research efforts are aimed at 
reducing molecular mobility to enhance physical stability. However, it is only recently, 
that researchers have attempted to predict crystallization on the basis of molecular 
mobility measurements 33a, 36a, 37.    
Traditionally, the glass transition temperature (Tg) has been considered as a marker of 
global mobility and based on that assumption, several studies have attempted to correlate 
it with physical stability. Many systematic studies have shown the effect of plasticizers 
compound which lower Tg) and anti-plasticizers (increase Tg) on the crystallization 
behavior of amorphous pharmaceuticals 38. However, there are several studies in the 
literature where the systems show drastically different crystallization behavior despite 
having nearly the same glass transition temperature 33c, 39.  
The molecular mobility responsible for the glass transition is cooperative in nature and is 
termed as global mobility 40. Structural relaxation or α- relaxations are often used 
interchangeably to describe global mobility.  The temperature dependence of structural 
relaxation above Tg is well described by the Vogel-Tamman-Fulcher (VTF) model 
41: 
                                                                         (1.8) 
where τ is the average α-relaxation time, T is the temperature; τo, D and To are constants 
where τo corresponds to the relaxation time of the unrestricted material, D is the strength 
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parameter and is a measure of the fragility of the material and To is considered to be the 
temperature of zero mobility (theoretical Kauzmann temperature) .  
Due to the extremely high viscosity, structural relaxation in the glassy state is very slow 
in timescales of interest. According to the Adam – Gibbs theory, molecular relaxation 
requires cooperative rearrangement of a group of molecules42. There is a marked increase 
in viscosity as the temperature decreases and the movement of one molecule will disturb 
an increasingly large number of its neighboring molecules. The energy barrier for 
molecular rearrangement is proportional to the size of rearranging unit. The relaxation 
time, τ, can be expressed as  
                              (1.9) 
In the above equation, Δμ is the potential energy barrier per molecule and Sc is the 
configurational entropy of the smallest rearranging unit. The configurational entropy, Sc,  
in supercooled liquids can be expressed using a hyperbolic relationship with temperature  
(Cp,conf = K/T, where K is a proportionality constant). In the glassy state, the Kauzmann 
temperature (approximated as T0) marks the lower limit of the excess entropy in the 
amorphous state. The concept of fictive temperature (Tf) was introduced by Tool and 
Narayanaswamy43. It is defined as the temperature at which a non-equilibrium property p 
(enthalpy or entropy) of a glass, in excess with respect to the stable crystalline state, 
would have the same value as in the equilibrium supercooled liquid. The configurational 
entropy can then be calculated as follows 
                                            (1.10) 
where ΔCp = Cp,l - Cp,g at To 
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In eq 1.10, Sc(To) is assumed to be 0 at To. By substituting eq 1.10 in the Adam-Gibbs 
model, eq 1.9 becomes 
                               (1.11) 
Eq 1.11 is also known as the Adam-Gibbs-Vogel equation and is used to calculate the 
temperature dependence of structural relaxation time in the glassy state. This model does 
not completely describe the non-linear and non-exponential nature (i.e. the β- parameter) 
of structural relaxation. Moreover, the effects of thermal history and preparation method 
on structural relaxation are not taken into account. However, the approach is 
experimentally convenient and has found extensive application27,44,45.  
The most successful phenomenological framework used to describe the structural 
relaxation behavior in glasses is the Tool-Narayanaswamy-Moynihan model43,46,47. It can 
explain the non-isothermal and non-exponential temperature of structural relaxation for 
complex temperature histories. The description of this model is given elsewhere48. 
Several techniques including differential scanning calorimetry (DSC) 49, dielectric 
spectroscopy 33b, c, 36a, 39a, 49a, shear viscosity measurement 50 and nuclear magnetic 
resonance 51 have been used to study structural relaxation in amorphous pharmaceuticals. 
Glassy systems exhibit local motions involving either the entire molecule or 
intramolecular reorientations and are termed as β- or secondary relaxations or “local 
mobility” 52. In contrast to the α-relaxations, they are non-cooperative in nature and are 
typically much faster with relaxation time < 10-1 seconds. They show an Arrhenius 
temperature dependence and are characterized by a much smaller activation energy as 
compared to α-relaxations53. Unlike α-relaxation, a molecule can possess many local 
motions, the most important being the Johari-Goldstein (JG) relaxations 52a.  These 
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relaxations involve the motion of the entire molecule and are supposed to be the 
precursor to the cooperative α-relaxations54. Dynamic dielectric spectroscopy has been 
commonly used to investigate β-relaxations in amorphous pharmaceuticals 33b, c, 39a. 
1.4.1  Supercooled state 
 
Earlier work from Ngai et al demonstrated partial coupling between crystallization rate 
and structural relaxation time for trinapthylbenzene and 1,2-diphenylbenzene 34b. 
Previous work from our laboratory has established an excellent correlation between the 
α- relaxation time and crystallization onset time above Tg in amorphous pharmaceuticals 
33b, c, 39a. Systematic studies have been carried out to investigate the influence of additives 
such as plasticizers (sorbitol) and antiplasticizers (polyvinylpyrrolidone; PVP) on global 
mobility and crystallization of amorphous sucrose 39a. PVP showed an antiplasticization 
effect whereas sorbitol plasticized the global motions in amorphous sucrose. The 
influence on global mobility correlated well with the crystallization onset time. In another 
similar study of amorphous solid dispersions of itraconazole and 
hydroxypropylmethylcellulose acetate succinate (HPMCAS), HPMCAS significantly 
increased the α- relaxation time which translated to an increase in crystallization onset 
time55. Bhardwaj et al demonstrated the influence of preparation method (freeze-drying; 
spray drying and dehydration) on molecular mobility and crystallization behavior of 
amorphous trehalose33c. A strong coupling between the crystallization onset time and 
global mobility enabled development of predictive models. An excellent agreement was 
observed between the experimental and predicted onset time for crystallization around Tg. 
The α- relaxation appears to be strongly coupled to the physical instability observed 
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above Tg in case of trehalose and itraconazole. However, it remains to be established if 
such a correlation exists in a wide variety of amorphous pharmaceuticals. 
1.4.2 Glassy state 
 
Two kinds of dynamics are observed in the glassy state: local mobility as evidenced by 
secondary relaxations and global mobility or slow dynamics due to the segmental 
motions which, although characterized by long relaxation times, are not completely 
frozen 41b, 56. DSC and time domain dielectric spectroscopy have been employed to study 
the structural relaxation below Tg in amorphous pharmaceuticals 
36a, 37a, b, 41b, 56. DSC, 
frequency domain dielectric spectroscopy and spin-lattice relaxation time measurement 
have been utilized to investigate the local mobility in the glassy regime of 
pharmaceuticals 33b, 39a, 57. There are several studies showing evidence of nucleation or 
crystallization at temperatures far below Tg 
36a, 37, 57a, 58. However, there is a lack of 
understanding of factors governing crystallization in glassy pharmaceuticals.  
There are a few studies in the literature evaluating the potential role of local mobility in 
determining the physical stability of amorphous pharmaceuticals. Vyazovkin et al 
observed endothermic peaks almost 50 °C below Tg and attributed them to β-relaxation 
58-59. In a follow up study, the peaks  were correlated with nucleation in the glassy state 
57a. It was suggested that β-relaxation may control the crystallization process in this 
temperature range where α-relaxation is thought to be negligible. In another study, 
molecular mobility in amorphous salicin and indomethacin below Tg was probed using 
nuclear magnetic resonance 57b.  The molecular mobility was faster in salicin as compared 
to indomethacin and this correlated with the crystallization behavior. However, enthalpic 
relaxation studies were not able to provide insight into the observed crystallization 
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behavior. Bhugra and Pikal speculate that if local mobility renders the molecules in a 
certain conformation feasible for nucleation, then β-relaxation would be correlated to the 
crystallization behavior 29. Few studies have shown a direct correlation of chemical 
stability with local mobility reinforcing its potential significance 60. However there are no 
studies in the literature demonstrating a direct correlation between β-relaxation and 
crystallization behavior.  
Aso et al calculated the mean relaxation time for amorphous nifedipine and phenobarbital 
using the Adam-Gibbs-Vogel (AGV) equation and it correlated well with the 
crystallization rate though a partial decoupling was observed in the case of amorphous 
nifedipine34a. In another study, the authors attempted to predict crystallization onset 
below Tg from correlations observed above Tg in amorphous sucrose 
36a, 37a. The 
predictions were based on the assumption that similar motions are being measured by 
dielectric spectroscopy above Tg and calorimetry below Tg. However, reliable prediction 
of crystallization onset time was not possible.  They observed coupling between 
crystallization onset and mobility above Tg. In an effort to predict crystallization, similar 
coupling was assumed below Tg which may not be the case. In a follow up study, the 
authors utilized the same approach to predict crystallization at pharmaceutically relevant 
temperatures below Tg for a group of compounds 
37b. However, a good agreement was 
observed in only two of the four investigated compounds indicating that the assumptions 
may not be valid in all cases. In view of the current understanding, it seems important to 
investigate the dynamics (local and structural relaxations) in the glassy state of 
amorphous pharmaceuticals and establish a correlation with crystallization over a 
pharmaceutically relevant temperature range below Tg. 
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1.5 Influence of water on physical stability 
 
It is difficult to prepare pharmaceutical dosage forms where water is completely 
excluded. This will be especially challenging in amorphous materials which have an 
extremely strong tendency to sorb moisture. Water, by increasing the free volume, 
plasticizes amorphous materials. This results in reduction of glass transition temperature 
and increased mobility 61. Amorphous pharmaceuticals can sorb water during processing 
and/or storage thus making it important to understand the role of water in influencing the 
physical instability in these systems. However, very few studies in the pharmaceutical 
literature have investigated the influence of water on accelerating crystallization 38a, 38c, 62. 
As mentioned earlier, Tg has been considered to be a determinant of physical stability and 
attempts have been made to develop models to predict Tg as a function of water content 
62c. However, this information would not allow the pharmaceutical formulator to 
accurately predict physical stability of amorphous pharmaceuticals.  The increase in 
relative humidity accelerated crystallization in amorphous sucrose and glucose 63. It was 
attributed to the decrease in viscosity leading to increased probability of nucleation 
followed by crystallization. A decrease in peak crystallization temperature was observed 
with increasing water content during non-isothermal crystallization studies of amorphous 
lactose 64. Water has a strong plasticizing effect as observed in amorphous indomethacin, 
wherein sorption of 1% w/w water resulted in a 10 °C reduction in Tg 
38a. In the same 
study, the authors noted the overall rate of crystallization decreased as the RH increased 
from 21% to 43% which seems counterintuitive. However, this was attributed to surface 
initiated crystallization below 21% RH requiring less mobility as compared to the bulk 
crystallization prevalent above 21% RH which would require comparatively higher 
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mobility.   The influence of water on mobility has been investigated using dielectric 
spectroscopy, nuclear magnetic resonance (NMR) and differential scanning calorimetry 
62a, 65. With increase in RH of colyophilized sucrose-PVP mixtures, no change in motions 
of MHz-order was observed either in the  side chain of PVP or sugar ring in sucrose 65b. 
However, a small increase in mid-KHz-order motions was observed for sucrose in 
colyophilized mixtures. An increase, although small, in T1 relaxation time was observed 
in fused nifedipine-excipient mixtures with increase in water content 62a. However, the 
type of mobility measured by NMR is unclear i.e. whether it is α- or β-relaxation. 
Andronis et al showed a significant increase in mobility of amorphous indomethacin at 
56% and 83% RH measured using DES and presence of water did not seem to influence 
the fragility 65a.  An increase in water content had an opposite effect on the different local 
motions (γ- and β- relaxation) in amorphous lactose 66. They observed a drastic decrease 
in the relaxation time of β motions, which they refer to as the Johari Goldstein motions, 
and saw an increase in relaxation time of γ- motions attributed to the bridging effect of 
water between the adjacent hydroxymethyl groups. Similar results were obtained in 
amorphous cyclodextrins wherein the addition of water influenced the activation energy 
barrier for γ- and β- relaxation in completely opposite ways 67. Similarly, in amorphous 
glucose, an increase in water content shifted the α-relaxations to a lower temperature and 
β-relaxations to a higher temperature 65c. These results make it important to investigate 
the influence of water on mobility in cases where it plays a role in physical stability of 
amorphous pharmaceuticals. 
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1.6 Thesis overview and hypotheses 
 
Chapter 2 
The extremely long time scale of global motions and the non-ergodic nature of glasses, 
pose a challenge in experimentally characterizing the structural relaxation. The non-
exponential, non-linear and history dependence of structural relaxation needs to be 
suitably addressed by the model to accurately estimate the relaxation time. However the 
Adam-Gibbs model, commonly employed in the pharmaceutical community does not 
adequately capture all the key features of structural relaxation mentioned above. Our 
primary objective was to comprehensively characterize the structural relaxation behavior 
in glassy nifedipine using dielectric spectroscopy.  
The importance of “physical aging” stems from the fact that it could lead to a glassy 
matrix closer to the equilibrium state. If the mobility (measured as relaxation time) 
governs stability, aging by reducing the mobility can serve as an effective stabilization 
strategy. In fact, annealing (deliberate physical aging) has been shown to improve the 
chemical stability of peptides. In this study, we comprehensively studied the effect of 
physical aging on the structural relaxation behavior at several temperatures. To the best 
of our knowledge, this is the first direct experimental measurement of structural 
relaxation time in pharmaceutical glasses.  
Chapter 3 
Physical instability or crystallization during manufacture or storage can adversely affect 
the amorphous drug product performance. Therefore, factors governing stability should 
be thoroughly and comprehensively investigated in order to develop predictive models 
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for crystallization. Several reports have shown a correlation between global motions and 
physical stability in the supercooled state. However, amorphous pharmaceuticals are 
typically stored as glasses. Thus, evaluation of such correlations in this state is of 
immense practical value. We had two specific objectives: (i) comprehensively 
characterize the molecular mobility, i.e. both global and local motions, in supercooled 
and glassy states of two model compounds (celecoxib and indomethacin) and (ii) 
investigate the potential correlation between crystallization and the specific mobility 
mode in the glassy state. This would enable the development of stabilization approaches 
by modulating the specific mobility correlating with the observed physical instability. 
The working hypothesis was:  
Physical instability (measured as time for 2.5% crystallization) is correlated to global 
molecular mobility in glassy celecoxib and indomethacin. 
A combination of time and frequency domain dielectric spectroscopy was used to map 
the different types of molecular motions present in the glassy state. Isothermal 
crystallization was monitored by powder X-ray diffractometry using either a laboratory 
source (supercooled state) or synchrotron source (glassy state). Structural (α-) relaxation 
time correlated well with characteristic crystallization time in the supercooled state. On 
the other hand, a stronger correlation was observed between the Johari-Goldstein (β-) 
relaxation time and physical instability in the glassy state. These results suggest that 
Johari-Goldstein relaxation is a potential predictor of physical instability in the glassy 
state of these systems. 
Chapter 4 
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Solid dispersions, molecular drug − polymer mixtures, are known to physically stabilize 
amorphous drugs. However, the mechanism of stabilization by the polymer in the glassy 
state is not comprehensively understood. Our objective was to study the effect of (i) 
polymer additive and (ii) polymer concentration on the drug stability in NIF-polymer 
dispersions.  This will not only enhance our understanding of the basic mechanism of 
polymer stabilization, but also rationalize the polymer selection in the formulation of 
solid dispersions.  
The working hypotheses were:  
i. Time-temperature superposition (TTS) principle would be valid in solid 
dispersions enabling the calculation of temperature dependence of structural 
relaxation time in glassy dispersions.  
ii. The addition of polymer, affects the physical stability by influencing the molecular 
mobility of the resulting dispersion. 
iii. PVP, in a concentration dependent manner, will increase the relaxation time and 
thereby enhance the physical stability of nifedipine in glassy dispersions. 
Dielectric spectroscopy was used to characterize the structural relaxation in 
pharmaceutical dispersions containing NIF and either PVP or HPMCAS. For pure NIF as 
well as the dispersions, the validity of the TTS principle was established. We found that 
strong drug - polymer hydrogen bonding interactions improved the physical stability (i.e. 
delayed crystallization) by reducing the molecular mobility. The strength of hydrogen 
bonding, structural relaxation time and crystallization followed the order: NIF-PVP > 
NIF-HPMCAS > NIF. With an increase in PVP concentration, the relaxation times were 
longer indicating a decrease in molecular mobility. This is the first application of the 
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superposition principle to characterize structural relaxation in glassy pharmaceutical 
dispersions. 
Chapter 5 
Amorphous systems are typically characterized by a pronounced tendency to sorb water. 
This can potentially increase the risk of physicochemical instability. During the 
manufacture and storage of amorphous pharmaceuticals, there are practical limits to the 
extent to which the ambient water vapor pressure can be reduced. Thus, it is important to 
understand the role of sorbed water content on molecular mobility and consequently the 
crystallization behavior of amorphous pharmaceuticals. The objective of this study was to 
systematically vary the water content and determine the effects on (i) molecular mobility, 
and (ii) crystallization behavior. These investigations were conducted using nifedipine - 
polyvinylpyrrolidone vinyl acetate 64 (NIF - PVPVA) as a model solid dispersion. 
The working hypothesis was: 
Water, in a concentration dependent manner, increases the molecular mobility and 
accelerates crystallization of the drug in NIF - PVPVA dispersions - effects attributable 
to plasticization. 
The temperature scaling (Tg/T) allowed us to simultaneously evaluate the effects of water 
content and temperature on the relaxation time. In the supercooled dispersions, once 
scaled, the relaxation times of the systems with different water content overlapped. Thus, 
the observed increase in mobility could be explained by the “plasticization” effect of 
water. This effect also explained the decrease in crystallization onset temperature brought 
about by water. That is, plasticization is the underlying mechanism governing the 
observed increase in mobility and physical instability in the supercooled state.   
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Chapter 6 
One of the major challenges in the development of amorphous formulations is the reliable 
prediction of long term physical stability. Studying degradation kinetics at elevated 
temperatures and extrapolating to room temperature, an approach classically used for 
predicting chemical degradation, cannot be used for physical stability (crystallization) 
prediction. In this chapter, we are proposing the use of “water sorption” as an accelerated 
stability approach to predict crystallization in solid dispersions. The study was conducted 
using felodipine - polyvinylpyrrolidone (FEL-PVP) as a model solid dispersion.  
The working hypothesis was: 
At low water contents, the coupling coefficient between molecular mobility and 
crystallization time will remain unaffected in FEL - PVP dispersions 
With an increase in water content, the α-relaxation time (measured by dielectric 
spectroscopy) decreased reflecting an increase in molecular mobility. The temperature 
dependence of relaxation time indicated that the fragility of the dispersion was 
independent of the water concentration. The time for felodipine crystallization also 
decreased with an increase in water content. The plot of crystallization versus inverse 
temperature showed an Arrhenius temperature dependence. In the range of water contents 
studied, the slope value was independent of the water content. This indicates that the 
decrease in relaxation as well as crystallization time can be explained by the 
plasticization effect. The effect was manifested in the value of the coupling coefficient, a 
measure of the coupling between molecular mobility and crystallization time, which was 
unaffected by the water content in the dispersion.. Based on these findings, we are 
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proposing the use of “water sorption” as an “accelerated stability tool” to predict 
crystallization in dry dispersions.  
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2 Dielectric spectroscopy - a tool to characterize structural relaxation 
behavior in pharmaceutical glasses 
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2.1 Introduction 
 
A variety of materials including ceramics, polymers, foods and pharmaceuticals exist in 
or are deliberately prepared in the amorphous state. While the amorphous state can confer 
many desirable properties, the potential physical and chemical instability due to the 
higher free energy compared to its crystalline counterpart, remains a major challenge. 
This issue is of particular concern with small molecule pharmaceuticals and has been the 
subject of numerous investigations. Molecular mobility, which encompasses both global 
and local motions, has been proposed as a major factor governing crystallization as well 
as accelerating the chemical reactivity in the amorphous state1,2,3,4,5,6,7. Global motions 
are cooperative in nature and are also referred to as primary, structural, or α-relaxation. 
Fast non-cooperative motions, emanating from a part of a molecule or involving a 
complete molecule, are termed local motions or as secondary relaxations. This 
investigation deals exclusively with structural relaxation with a focus on the glassy state. 
In the glassy state, the structure evolves continuously towards equilibrium, and the 
relaxation time provides a measure of the mobility of the system.  The term physical 
aging is used to describe this phenomenon. The consequence of structural relaxation on 
material properties in polymers, ceramics and gels has long been established8,9,10,11,12,13,14. 
The theoretical and phenomenological aspects of structural relaxation have been the 
subject of several excellent reviews15,16,17,18. This subject has recently gained a lot of 
attention in the pharmaceutical literature. Several groups have documented a correlation 
between relaxation time and crystallization behavior in the supercooled state. The desired 
stability of amorphous pharmaceuticals necessitates their storage below the glass 
transition temperature. Thus, evaluation of such correlations in the glassy state is of 
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immense practical value. However, the extremely long time scale of these motions and 
the non-ergodic nature of glasses, pose a challenge in experimentally characterizing the 
structural relaxation. It is also necessary to recognize that the structural relaxation is non-
linear, non-exponential and history dependent. The consequences of these properties are 
not necessarily captured by the calorimetric approaches, widely used in pharmaceuticals. 
Recently, Mao et al19, using heat capacity measurements, developed a simulation model 
to estimate relaxation times. However, this does not provide a direct measure of the 
relaxation time. In order to explore potential correlation between structural relaxation and 
other properties of practical interest (such as crystallization and water sorption), direct 
experimental measurement of structural relaxation time is warranted.  
In this paper, we report the non-equilibrium structural relaxation behavior of glassy 
nifedipine using time domain dielectric spectroscopy, a method pioneered by Mopsik et 
al20,21. We have also studied the effect of physical aging on the relaxation time in the 
glassy state. The importance of “physical aging” stems from the fact that it could lead to 
a glassy matrix closer to the equilibrium state. If the mobility (measured as relaxation 
time) governs stability, aging by reducing the mobility can serve as an effective 
stabilization strategy. In fact, annealing (deliberate physical aging) has been shown to 
improve the chemical stability of peptides and antibiotics7, 22,23.   
2.2 Experimental section 
 
Preparation and baseline characterization of Amorphous Nifedipine. Nifedipine 
(C17H18N2O6) was purchased from Laborate Pharmaceutical Ltd, India and used as 
received. Nifedipine films (50 μm thick) were prepared by melting the crystalline powder 
between two electrodes (sample assembly of the dielectric spectrometer) followed by 
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quenching on an aluminum block precooled to -20 °C. From this point onwards, the 
sample was handled under “dry” conditions (in a glove box maintained at < 5% RH; RT).  
Dielectric spectroscopy. The experiments were performed using a time-domain 
dielectric spectrometer. A schematic of the experimental setup is shown in Figure 2.1. 
The sample cell assembly consists of two outer electrodes isolated with to provide 
electrical and thermal insulation. The inner electrodes (sample film sandwiched between 
two steel plates) are placed between the outer electrodes to form a parallel-plate 
capacitor. A power supply (TREK model 610C) is used to apply 200 V for 100 seconds 
to polarize the sample. The voltage drop across the integrating capacitor (2.2 nF), 
reflective of the polarization in the sample capacitor, was measured using an electrometer 
(Keithley 6514). The entire setup is controlled using a LABVIEW® program through a 
data acquisition board.   
Measurements above the glass transition temperature. The film sample was heated 
from room temperature to the temperature of interest. The voltage pulse was applied as 
soon as the temperature stabilized (± 0.2 oC). This was repeated for a series of 
temperatures above Tg as shown in Figure 2.2a.  
Measurements below the glass transition temperature. First, the measurements were 
carried out in samples out of equilibrium so as to obtain the relaxation time of a 
“minimally aged glass”. The sample was first heated to (Tg + 10 oC) to remove the effect 
of thermal history and then cooled to the desired measurement temperature. In order to 
ensure that the dielectric probe is not influenced by the ongoing structural recovery, the 
measurement time (in this case 100 seconds) was less than 10% of the aging time24. 
Therefore, after thermally equilibration, the sample was aged for 1020 seconds and then 
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pulsed. This cycle was repeated for a series of temperatures as shown in Figure 2.2b. In a 
second set of experiments, the dielectric response was monitored as the sample was aged 
isothermally (Struik’s protocol24). A fresh sample was used for each measurement 
temperature.  
Data analysis 
Relaxation time measurements. Time domain dielectric spectroscopy has been used to 
study the dynamics in glass forming materials, and specifically polymers25,26. In this 
technique, a constant dielectric stress (application of an electric field) is applied and the 
resultant dielectric strain (dielectric compliance) is measured as a function of time. The 
dielectric compliance is given by the relationship27:  
     (2.1) 
where ε(t) is the dielectric compliance, D(t) is the dielectric displacement, E is the 
applied electric field and εo is the dielectric permittivity of vacuum. The modified KWW 
function27 (eq 2.2) was used to fit the dielectric compliance measurements and a set of 
representative fitted parameters are provided in Table 2.1.  
   (2.2) 
In equation 2.2, ε1 is the zero time compliance, ε1 + ε2 is the long time plateau compliance, 
β is the shape parameter, τ is the relaxation time  and τc is the conductivity time.  
Time-temperature and time-aging time superposition. The superposition principle is 
based on the assumption that shape of the dynamic response curve (permittivity versus 
log time in this case) is independent of temperature or aging time. Thus, the curves can be 
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shifted horizontally to a reference curve thereby constructing a master curve in reduced 
time (tred).   
         (2.3) 
where a(i) is the horizontal shift factor and is determined by 
         (2.4) 
In equation 2.3 i can represent either temperature (T) or aging time and τ(i)r is the 
reference relaxation time. Instead of using the KWW equation to fit each curve, and then 
estimating τ(i) and a(i), the master curve was constructed by manual shifting. First a 
reference curve was selected and then the rest of the profiles, obtained at different 
temperatures, were superimposed on the reference curve by shifting along the time axis. 
The τ(i) was then determined as  
  (2.5) 
The curves superimposed very well except at short and long times (Figure 2.3). At short 
times, this observation is attributed to the appearance of a weak β-relaxation. The lack of 
superposition at longer time scales is due to interference from dc conductivity. Only the 
data ascribed to the structural relaxation, separated from the β-relaxation, was considered 
in this calculation. 
2.3 Results and discussion  
 
Non-isothermal relaxation behavior 
The increase in viscosity, as the temperature decreases, causes the dipoles to take longer 
to orient in the direction of the electric field. Hence, the dielectric compliance curves shift 
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to longer times  attributed to an increase in relaxation time (Figure 2.3). The steep rise 
after the secondary plateau is characteristic of dc conductivity25,28.    
In Figure 2.4, the conductivity term and the relaxation terms are plotted as a function of 
temperature. The data was fitted using the Vogel29 - Fulcher30 - Tamman31 (VFT) 
equation (eq 2.6) 
             (2.6) 
where τ is the relaxation time, T is the temperature and  τo, D and To are constants, τo is 
the relaxation time of the unrestricted material (10-14 s, the quasi-lattice vibration 
period15), D is the strength parameter and To is the temperature of zero mobility 
(theoretical Kauzmann temperature). The fitted parameters, provided in Table 2.2, are in 
agreement with previous literature reports32.  The D-value or the strength parameter, 
which is a measure of the kinetic fragility was ~ 7.2. This is in good agreement with the 
reported value of 7.3 and is indicative of a fragile glass former32. The calorimetric Tg 
typically exceeds the kinetic Tg  by 2 to 3 degrees and this difference varies with the 
fragility of the system33. Nifedipine exhibited a similar behavior. The kinetic Tg (Tg,kinetic) 
calculated using the VFT parameters, assuming  a relaxation time of 100 s, was ~ 40.9 oC, 
whereas the calorimetric Tg (Tg,cal) was 44.5 
oC. Unless otherwise mentioned, we will use 
the Tg,cal value.  
In the supercooled state, the temperature dependence of the relaxation time (τ) as well as 
conductivity (τc) is well described by the VFT model. However, since their fit parameters 
are different, a spread in the dielectric response is observed at longer times (Figure 2.3b). 
To eliminate the contribution of dc conductivity, the recoverable dielectric compliance εR 
(t) was estimated using equation 2.727 
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        (2.7) 
For each temperature, εR (t) was determined and plotted in Figure 2.5a. We observe an 
increase in ε1 and a slight decrease in ε2 as the temperature increased. This is in agreement 
with previous literature reports and is attributed to the “softening like” behavior of the 
secondary plateau25, 27. In equation 2.2, ε1 is related to the glassy (short time) response 
and ε2 is related to the transition to the long time plateau. In addition to the horizontal 
shift, the curves were shifted vertically to obtain a reasonable time-temperature 
superposition (Figure 2.5b). 
In the glassy state, structural rearrangement is manifested by a reduction in molecular 
mobility and reflected by an increase in relaxation time. The relaxation time increases by 
~ 3 orders of magnitude when the temperature decreases from Tg to (Tg – 14) (Figure 
2.6a). As we enter the glassy state, the structural relaxation appears to be “in equilibrium” 
up to (Tg – 6) and then diverges from the equilibrium supercooled line. Another way of 
interpreting the data is by analyzing in terms of Tf (Figure 2.6b). The slope of the line in 
the supercooled liquid region is 1.0 reflecting Tf = T at equilibrium.  On the other hand, 
as we enter the glassy state, the slope is approximately zero indicating that Tf does not 
change significantly with temperature and the glass is considered “stable”.  
Isothermal relaxation behavior 
DSC is the technique of choice to study the physical aging behavior of amorphous 
pharmaceuticals23,34,35,36,37. However, the enthalpic recovery measurements necessitate 
real time storage of the glass at the specific temperatures of interest.  Thus the 
experiments can become time consuming.  In the dielectric physical aging carried out 
using the Struik’s protocol24,38, snapshots (dielectric response) are taken at regularly 
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timed intervals to track the path towards equilibrium. The material is considered to have 
“aged into equilibrium” when the dielectric response ceases to evolve. Physical aging 
studies were carried out at several temperatures below Tg. At (Tg – 2), the dielectric curve 
obtained after aging for 0.5 and 1 h  completely overlapped implying completely 
relaxation into equilibrium in  ≤  1 hour  (Figure 2.7a). Similar results were obtained at 
(Tg – 4) and (Tg – 6) (Figure 2.7b and c). With a decrease in temperature, it takes longer 
to achieve equilibrium as can be seen at (Tg – 12) (Figure 2.8a). As the aging time is 
increased, the curve is shifted to the right on the time axis i.e. the response is shifted to 
longer times. With aging, the free volume decreases and it takes longer for the dipoles to 
orient in the direction of the electric field. We used the principle of time - aging time 
superposition39 to horizontally shift the curves onto a reference aging time curve (te = 
0.5h) and obtain a master curve (Figure 2.8b). The successful construction of the master 
curve indicates that the shape parameter, β, remains unchanged during aging as has been 
shown in the polymer literature40,41, 42. The master curve provides the time dependence of 
aging time shift factor39,(ate), similar to the temperature shift factor (aT). From this 
information, we calculated the relaxation time as a function of aging time (Figure 2.9a). 
Since the motions are faster near the glass transition, the sample ages into equilibrium 
within 0.5 h whereas, at lower temperatures, aging becomes slow and is not complete 
even after 16 h. At (Tg – 10) and (Tg – 12), a sharp increase in relaxation time is observed 
in the first 4 h and then the change is less pronounced. Such an effect of physical aging 
on relaxation time  has been reported for  numerous compounds26,43,44,45. At temperatures 
lower than (Tg - 8), the aging studies had to be discontinued because of crystallization 
(data not shown).  
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A stretched exponential function (eq 2.8) was used to fit the isothermal aging data 
obtained at select temperatures. 
    (2.8) 
where Tf is the fictive temperature, Ta is the annealing temperature, A is the pre-
exponential factor, β is the stretched exponential and t is the aging time. Tf  is defined as 
the temperature at which a non-equilibrium property p (enthalpy or entropy) of a glass, in 
excess with respect to the stable crystalline state, would have the same value as in the 
equilibrium supercooled liquid. In this case, Tf was estimated by the following 
relationship: τ(T)|glass = τ(Tf)| supercooled liquid. We resorted to this approach since there was 
insufficient data to obtain a reasonable slope value in the glassy state. Equation 2.8 was 
fit to the data using MATLAB to minimize the least-squared criteria. First the model was 
used to fit the data set at 37 oC by allowing all the parameters to vary. We obtained a β 
value of 0.52 at 37 oC. Typically values between 0.2 and 0.8 have been observed for 
small molecule glass formers. Variation of all parameters provided physically 
insignificant values for the 33 and 35 oC data. Hence, the β parameter was fixed at 0.52 
for both 33 and 35 oC. In addition, for 35 oC, the τ value was constrained to obtain a 
reasonable trend in τ values as a function of temperature. The fitted profiles are shown as 
black solid lines in Figure 2.9b. The few data points limit us from obtaining a reasonable 
fit. However, this study lays the groundwork for future in-depth investigations to model 
the structural relaxation behavior and predict the behavior under any given thermal 
history. The fit parameters obtained using the approach described above are provided in 
Table 2.3. The relaxation time, obtained from the fitting procedure, increases as the 
temperature decreases due to an increase in viscosity. The fitted τ values for 35 and 37 
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oC, unlike 33 oC, are in good agreement with the equilibrium supercooled liquid. This 
may be because at these temperatures, the glass has aged closer to equilibrium as 
compared to 33 oC. For all aging temperatures, δ decreases as time evolves and 
approaches zero asymptotically (Figure 2.9b). As the aging temperature decreases, δ 
increases and the curves will eventually approach zero at longer times.  
Figure 2.10 provides a comprehensive picture of the time and temperature dependence of 
structural relaxation (two essential characteristics) across the glass transition for 
nifedipine aged for different times (≤16 h). Aging led to an increase in the activation 
energy of structural relaxation and the glass progressively moved towards the VFT line, 
i.e. the “equilibrium behavior”.  
 
2.4 Significance and practical implications.  
 
Many amorphous materials, specifically drug substances, are stored in the glassy state. 
The molecular mobility is of great relevance in light of its potential influence on 
numerous properties of practical interest including stability and water sorption 
behavior46,47,32. If these properties are directly correlated to molecular mobility, as has 
been demonstrated in a limited number of systems, rapid attainment of “equilibrium” 
may be desirable. This is the first investigation in a drug substance, detailing the direct 
measurement of the relaxation behavior (evolution of relaxation time).  
Both the method of preparation of a glassy drug substance and the presence of additives 
(commonly referred to as excipients) in a drug product provide an avenue to modulate 
mobility. Bhardwaj et al43 have shown the effect of preparation method on the mobility of 
glassy trehalose and further linked it to stability. Trehalose exhibits an unusual behavior 
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in that the structural relaxation below Tg is fast enough to be monitored by frequency 
domain dielectric measurements. However, such fast dynamics is not expected in a 
majority of organic compounds including pharmaceuticals. In these cases, time domain 
dielectric spectroscopy will be the technique of choice. Therefore, the next logical step 
will be to evaluate the effect of preparation method and excipients on the relaxation 
behavior (evolution of relaxation time) of pharmaceutical glasses.  
2.5 Conclusions 
 
Time domain dielectric spectroscopy was used to experimentally characterize the 
structural relaxation behavior in glassy nifedipine. Time - aging time and time - 
temperature superposition principle enabled us to calculate the time and temperature 
dependence of relaxation time. The departure from equilibrium during isothermal aging 
was well described by the stretched exponential fit. To the best of our knowledge, this is 
the first comprehensive investigation of structural relaxation behavior in a pharmaceutical 
glass. In light of the potential correlation between mobility and physical stability, the 
relaxation behavior is of significant practical importance.  
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Figure 2-1 Schematic of the time domain dielectric spectrometer built in-house in the 
laboratory 
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Figure 2-2 Schematic of the experimental protocol for time domain dielectric 
measurements performed (a) above and (b) below the glass transition temperature (for a 
minimally aged glass). The arrow indicates the application of dielectric probe (200 V, 
100 s). Complete experimental details are provided in the text.  
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Figure 2-3 (a) The temperature dependence of the dielectric compliance response of 
nifedipine at temperatures above Tg (in equilibrium) and below Tg (non-equilibrium). The 
lines are the modified KWW function fitted curves. (b) The master curve was obtained 
using the principles of time-temperature superposition, with 47 oC as the reference 
temperature. 
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Figure 2-4 The dc conductivity term (τc) and dielectric relaxation time (τ) plotted as a 
function of temperature above Tg. The lines represent the VFT fits.   
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Figure 2-5 (a) The temperature dependence of the recoverable dielectric compliance 
response from 31 to 62.5 oC. (b) The master curve drawn with 47 oC as the reference 
temperature.  
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Figure 2-6 Plot of (a) temperature dependence of relaxation time and (b) Tf vs T in 
amorphous nifedipine 
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Figure 2-7 Time dependence of dielectric compliance at (a) 43 oC (Tg – 2), (b) 41 oC (Tg - 
4),  and (c) 39 oC (Tg – 6) 
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Figure 2-8 (a) Time dependence of dielectric compliance at 33 oC (Tg - 12) and (b) the 
master curve obtained using the principles of time - aging time superposition with 0.5 h 
curve as the reference. 
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Figure 2-9 Plots of (a) average structural relaxation time and (b) departure from 
equilibrium, versus aging time. In the left panel, the solid lines are drawn to aid in 
visualizing whereas in the right panel the solid lines are the fitted profiles obtained using 
eq 2.8. For 35 oC, only the first four data points were used for fitting.   
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Figure 2-10 Comprehensive plot of the relaxation dynamics showing both the time and 
temperature dependence of structural relaxation 
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Table 2.1 Fit parameters for equation 2.2 at 52.5 oC (errors represent the standard errors 
of estimate for the fit parameters) 
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Table 2.2 VFT parameter values obtained from model fitting of the relaxation time data 
(standard errors of fit are in parentheses).  
 
 
 
 
 
 
DTo To  (K) 
Nifedipine 1898 (42) 262 (1) 
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Table 2.3 Stretched exponential (eq 2.8) fit parameters obtained from model fitting of (Tf 
- Ta) versus logarithm of aging time  
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3 Correlation between molecular mobility and physical stability in 
supercooled & glassy pharmaceuticals* 
 
 
 
 
 
 
 
*Reproduced in part with permission from Mehta, Mehak, et al. "Correlation 
between Molecular Mobility and Physical Stability in Pharmaceutical 
Glasses." Molecular pharmaceutics 13.4 (2016): 1267-1277. Copyright 
(2016) American Chemical Society 
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3.1 Introduction 
 
A large fraction of the new drugs under development are characterized by poor aqueous 
solubility1. As a result, their absorption following oral administration can be a challenge. 
Drug amorphization is an effective and popular strategy to enhance solubility2. However, 
a major challenge with this approach is the risk of crystallization due to physical 
instability. This can negate the bioavailability advantage brought about by the solubility 
enhancement. Hence, current research efforts are directed towards understanding the 
factors influencing crystallization. Molecular mobility has been extensively investigated 
in light of its possible role in governing physical stability3,4,5,6,7. Molecular mobility 
comprises both global and local motions. Global motion is cooperative in nature, and 
responsible for bringing about the glass transition. It is also referred as α- or structural 
relaxation. On the other hand, local motions (or secondary relaxations) are non-
cooperative in nature and arise from either a part or an entire molecule8,9. In several 
compounds, structural relaxation time has been linked to physical stability in the 
supercooled state (T > Tg)
10,11,12. Interestingly, β-relaxation (also referred to as Johari-
Goldstein relaxation13) has been implicated in physical instability of glasses (T < 
Tg)
14,15,16,17. Since amorphous pharmaceuticals are typically stored as glasses, evaluation 
of such correlations in this state is of immense practical value.  
The structural relaxation time in the supercooled state is typically < 102 s, whereas below 
Tg, the relaxation time can be very long. Thus experimental measurement of the structural 
relaxation time can be very challenging. As a result, in several compounds including 
nifedipine, griseofulvin, phenobarbital and sorbitol, structural relaxation times have been 
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estimated using different modifications of the Adam-Gibbs model5,7,18,19,20. In light of the 
potential limitations of this model21,22, direct experimental measurement of the structural 
relaxation time would be useful. Experimental measurements rely on evaluating the 
kinetics of structural relaxation following an environmental perturbation18,23,24. 
Mechanical measurements (for example, stress relaxation) can provide insight into 
transport properties such as viscosity and relaxation time25. While this approach warrants 
further investigation, the brittle nature of pharmaceutical compounds may limit our 
ability to perform these measurements. Differential scanning calorimetry (DSC) provides 
an “average” measure of mobility but does not provide direct information about the 
contribution from different types of molecular motions. Dielectric spectroscopy (DES) 
allows direct measurement of molecular motions associated with dipole reorientation in 
the frequency range of 10-6 to 1012 Hz24, 26. Time domain dielectric techniques such as 
isothermal depolarization and thermally stimulated current have been employed to 
characterize molecular motions in glassy pharmaceuticals27,28. In this report, we have 
used a combination of time domain and frequency domain dielectric techniques to 
comprehensively map the molecular dynamics (i.e. α and β-relaxation)  in glassy and 
supercooled states.   
Recently, Cicerone et al29 showed that protein stability in numerous sugar matrices (> 
100) was directly linked to β-relaxation processes.  A similar result was observed in 
naproxen glass wherein the Johari-Goldstein relaxation was shown to be responsible for 
the physical instability30. Crystallization in glassy fulvene and indomethacin has also 
been circumstantially linked to β-relaxation14,17. On the other hand, in several 
pharmaceutical glasses including nifedipine, griseofulvin, phenobarbital and  sucrose, the 
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structural relaxation time below Tg was shown to be coupled to crystallization
3,5,18,19. 
However, in these cases, the relaxation time was either an estimate obtained using the 
Adam-Gibbs model or was obtained using DSC. While both α and β-relaxations have 
been shown to influence the physical stability in the glassy state, very few studies have 
systematically and comprehensively characterized all the mobility modes which may 
influence crystallization in the temperature range of interest. We had two specific 
objectives in order to accomplish this goal: (i) comprehensively characterize the 
molecular mobility, i.e. both global and local motions, in supercooled and glassy states of 
two model compounds (celecoxib and indomethacin) and (ii) investigate the potential 
correlation between crystallization and the specific mobility mode in the glassy state. The 
model compounds were chosen since they can be readily rendered amorphous by melt 
quenching14,31 and tend to crystallize rapidly in the glassy state6,32. This enabled the 
development of correlation models to predict crystallization in systems of interest. The 
ultimate aim is to enable the development of stabilization approaches by modulating the 
specific mobility correlated with the observed physical instability. 
3.2 Experimental section 
 
Preparation of amorphous materials. Celecoxib (C17H14F3N3O2S, purity > 98%) and 
indomethacin (C19H16ClNO4, purity > 98%; γ-form) were used as received. Amorphous 
samples were prepared by melting the crystalline powder followed by quench cooling on 
aluminum blocks precooled to -20 °C. The melt was lightly crushed using a mortar and 
pestle in a glove box at room temperature (< 5% relative humidity). The films were 
prepared in a similar manner by melting the powder between the two electrodes (sample 
assembly of the dielectric spectrometer) followed by quench cooling. Further handling 
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was done at room temperature under “dry conditions” (in a glove box maintained at < 5% 
RH).  
Differential Scanning Calorimetry. A differential scanning calorimeter (Q2000, TA 
Instruments, New Castle, DE) equipped with a refrigerated cooling accessory was used. 
The instrument was calibrated with tin (SRM 741a, NIST). The sample was accurately 
weighed and sealed in hermetically sealed aluminum pans. All the measurements were 
done under dry nitrogen purge (50 ml/min) at a heating rate of 10 oC/min following a 
cooling at the same rate. The Tg was determined as the midpoint of the glass transition 
region in the DSC curves.  
X-ray diffractometry (XRD). A powder X-ray diffractometer (D8 ADVANCE; Bruker 
AXS, Madison, WI, USA) equipped with a variable temperature stage (TTK 450; Anton 
Paar, Graz-Straßgang, Austria) and Si strip one-dimensional detector (LynxEye™; 
Bruker AXS) was used. The isothermal crystallization kinetics, in the supercooled state, 
was evaluated at several temperatures. The powder samples were periodically exposed to 
Cu Kα radiation (40 kV & 40 mA), and the diffraction patterns were obtained under dry 
nitrogen purge by scanning over an angular range of 5 to 40° 2θ with a step size of 0.05° 
and a dwell time of 0.5 s. 
Synchrotron XRD (SXRD; transmission mode). The enhanced sensitivity of this 
technique enabled us to monitor low levels of crystallization. Powdered samples, stored 
at several temperatures in the glassy state, were hermetically crimped in DSC pans and 
exposed to synchrotron radiation. Experiments were performed in the transmission mode 
in the 17-BM-B beamline at Argonne National Laboratory (Argonne, IL, USA). A 
monochromatic X-ray beam [wavelength 0.75009 Å; beam size 250 μm (horizontal) × 
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160 μm (vertical)] and a two-dimensional area detector (XRD-1621, PerkinElmer) were 
used. Calibration was performed using an Al2O3 standard (SRM 674a, NIST). Using a 
stepper motor, the sample was oscillated (±1 mm from the center along the horizontal 
axis) during data collection. Each sample was scanned at 30 points, with an exposure 
time of 1 s for each scan (2 mm/30 seconds), and the results were averaged. The raw 
images were integrated to yield one dimensional d-spacing (Å) or 2θ (°) scans using the 
GSAS II software developed by Brian H. Toby and Robert B. Von Dreele at Argonne 
National Labs33.  
Quantification of XRD data. At each time point, crystallinity index was calculated 
using eq 1. The crystallinity index can be considered equivalent to the % crystallinity, if 
the total integrated intensity (amorphous + crystalline) remains constant throughout the 
isothermal crystallization experiment34.  
        (3.1) 
To quantify the crystallinity index, a custom-built program (using Fortran 77) was used. 
In this program, the amorphous intensity contribution was based on the experimental 
XRD pattern of the amorphous “reference” material. The subtraction of the amorphous 
intensity from the total pattern yielded the intensity contribution from the crystalline 
peaks. The percent crystallinity was plotted as a function of time, and a characteristic 
crystallization time (tc) was obtained for a desired level of crystallization. The time taken 
for 2.5% of the drug to crystallize was defined as the characteristic crystallization time 
(tc) for both above and below Tg. 
Dielectric spectroscopy (DES).  The molecular mobility was comprehensively 
characterized using both time and frequency domain dielectric spectrometers. The film 
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samples, 50 μm thickness, were sandwiched between two round electrodes (stainless steel 
and copper electrodes were used in time and frequency domain setup respectively). The 
secondary relaxations were characterized using a high performance frequency analyzer 
(Novocontrol Alpha-A, Novocontrol Technologies, Germany). The isothermal dielectric 
measurements were carried out in the frequency range of 10-2 to 107 Hz between -100 and 
80 oC.   
The structural relaxation time, in both glassy and supercooled states, was measured using 
an in-house built time domain dielectric spectrometer35. For measurements in the 
supercooled state, the film sample was heated from room temperature to the temperature 
of interest. The voltage bias (200 V for 100 seconds) was applied as soon as the 
temperature stabilized (± 0.2 oC). This was repeated for a series of temperatures above 
Tg. In the glassy state, the measurements were carried out in “minimally aged glasses”. 
The sample was first heated to (Tg + 10 
oC) to remove the effect of thermal history and 
then cooled to the desired measurement temperature. In order to ensure that the dielectric 
probe is not influenced by the ongoing structural recovery,  the measurement time (in this 
case 100 seconds) was less than 10% of the aging time36. Therefore, after thermal 
equilibration, the sample was aged for 1020 seconds and then pulsed. This cycle was 
repeated for a series of desired temperatures.  
3.3 Data analysis 
 
Frequency domain dielectric spectroscopy.   
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The secondary relaxations were fitted using the Cole - Cole37 function (eq 3.2; an 
empirical function described in detail by Kremer38) to obtain the average relaxation time 
(τFD; FD - Frequency domain). 
         (3.2) 
        (3.3) 
In eq 3.2, ω is the angular frequency, ε*(ω) is the complex dielectric permittivity (eq 3.3) 
consisting of real (ε’) and imaginary components (ε”) and Δε is the dielectric strength 
given by Δε = εs - ε∞ where εs, static permittivity, gives the low frequency limit (ω→0) of 
ε’(ω) and ε∞ gives the high frequency limit (ω→∞) of ε’(ω). The shape parameter (γ) can 
take values from 0 to 1 and accounts for the symmetrical broadening of the relaxation 
function in eq 3.2.  
 
 
Time domain dielectric spectroscopy.  
 
In this technique, a constant dielectric stress (application of an electric field) is applied 
and the resultant dielectric strain (dielectric compliance) is measured as a function of 
time. The dielectric compliance (ε) is given by the relationship38:  
     (3.4) 
where D is the dielectric displacement, E is the applied electric field and εo is the 
dielectric permittivity of vacuum. 
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The dielectric compliance behavior obtained could be described by the modified 
Kohlrausch39 William-Watts40 equation (KWW)41 (eq 3.5), which includes the 
conductivity contribution.  
    (3.5) 
where ε1 is the zero time compliance, (ε1 + ε2) is the long time plateau compliance, β is 
related to the breadth of the relaxation spectrum, τ and τc are the relaxation and 
conductivity times respectively. If β remains constant with temperature, then the curves at 
different temperatures can be shifted horizontally to a reference curve thereby 
constructing a master curve in reduced time (tred).   
         (3.6) 
In eq 3.6, aT is the temperature shift factor and is expressed as: 
    (3.7) 
wherein Tref is the reference temperature. This is known as the time-temperature 
superposition (TTS) principle42,43 an approach routinely used in polymer 
characterization44. Instead of using the KWW equation to fit each curve, and then 
estimating τ(T) and aT, the master curve was constructed by manual shifting. First a 
reference curve was selected and then the rest of the profiles, obtained at different 
temperatures, were superimposed on the reference curve by shifting along the time axis. 
The  τTD(T) was then determined as  
  (3.8) 
where the τ(Tref)  is determined from the fit to equation 3.5 for the data at Tref. At short 
times, the curves did not superimpose well due to presence of a weak β-relaxation (Figure 
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3.1). Only the data ascribed to the structural relaxation, separated from the β-relaxation, 
was considered in this calculation.  
While the absolute relaxation times obtained from frequency and time domain dielectric 
measurements are not comparable, they exhibit the same temperature dependence.  
3.4 Results and discussion 
 
Baseline characterization. The amorphous materials were observed to be X-ray 
amorphous. The calorimetric glass transition temperatures (Tg,cal; celecoxib 55.3 ± 0.4 °C 
and indomethacin  45.1 ± 0.5 °C) were in good agreement with the literature values23,45,46. 
(DSC curves are included in Figure 3.10). The water content, determined by Karl Fischer 
titrimetry, was < 0.5% w/w.  
Structural relaxation behavior. Figure 3.1a shows the dielectric response curves of 
celecoxib over a temperature range (39 to 65 °C) spanning the glassy and supercooled 
states.  With a decrease in temperature, the observed shift in the dielectric response 
curves can be ascribed to an increase in relaxation time. The steep rise after the secondary 
plateau is attributed to dc conductivity38. Similar results were observed in case of 
indomethacin (Figure 3.1b).  
Supercooled state. The average structural relaxation times (τTD), obtained by the TTS 
principle described earlier, were determined at several temperatures above Tg. The 
temperature dependence (Figure 3.2; black filled circles) was well described by the 
Vogel47 - Fulcher48 - Tamman49 (VFT) model (eq 3.9) 
             (3.9) 
where T is the temperature and  τo, D, To are constants, τo is the relaxation time of the 
unrestricted material (10-14 s, the quasi-lattice vibration period50), D is the strength 
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parameter47,48,49 and To is the temperature of zero mobility (theoretical Kauzmann 
temperature). The VFT parameters are shown in Table 3.1 and are in agreement with 
literature values6,45. The fragility index51,52, m, is related to D by eq 3.1051 and the 
calculated values are provided in Table 3.1.  
      (3.10) 
These values (low D and high m) are indicative of fragile glass formers. The dielectric Tg 
values calculated using the VFT parameters, assuming  a relaxation time of 100 s, were 
49.5 oC and 41.4 oC for celecoxib and indomethacin respectively. These are in good 
agreement with the literature values of 54.8 oC (celecoxib) and 41 oC (indomethacin) 
obtained using dielectric spectroscopy6,28. Unless otherwise mentioned, we will use the 
Tg,cal values. 
Glassy state. In the glassy state, the structural relaxation slows down drastically, reflected 
by an increase in relaxation time. These motions appear to be “in equilibrium” up to (Tg – 
6) and then diverge from the equilibrium supercooled line. The structural relaxation time 
increases by ~ 2.5 orders of magnitude as the temperature decreases from Tg to (Tg - 14) 
(Figure 3.2). The TTS principle enabled us to obtain the absolute structural relaxation 
time in the glassy state where the relaxation becomes extremely slow. 
Secondary relaxations. Isothermal dielectric experiments. Isothermal frequency sweeps 
were carried out at several temperatures ranging from -100 to 80 oC. A representative 
dielectric curve for celecoxib and indomethacin above Tg is shown in Figure 3.3. 
Interestingly, an excess wing was observed in the high frequency tail of the α-relaxation 
peak. This is a common feature of glasses, shown to be the high frequency flank of the 
βJG relaxation, but masked by the α-relaxation contribution53. In an effort to check if the 
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excess wing is truly originating from the βJG relaxation, we used the Ngai’s coupling 
model54,55. This model considers the βJG relaxation (referred to as independent relaxation, 
τo) to be the true precursor to α-relaxation (eq 3.11).  
        (3.11) 
In this equation,  βKWW is a measure of the deviation from exponential decay of the α-
relaxation peak and τc is the crossover time, typically ~2 ps in most glass formers54. The 
calculated primitive relaxation frequency (fo = 1/2πτo), in representative spectra of 
celecoxib and indomethacin, are shown in Figure 3.3. It can be seen that the calculated 
value of fo lies in the frequency range where Havriliak Negami model for a single 
relaxation (α-), no longer adequately describes the data. Hence, the observed excess wing 
is truly characteristic of the hidden βJG relaxation.  
Temperature dependence of secondary relaxations in celecoxib. Three secondary 
relaxation peaks were observed between -90 and  50 oC - the slowest β process, the faster 
γ process and the fastest δ process (Figure 3.4). As can be seen in Figure 3.2, the 
temperature dependence of these relaxations were well described by the Arrhenius 
equation:  
      (3.12) 
where τ∞ is the pre-exponential factor, ΔE is the activation energy and k is the Boltzmann 
constant. The fitting parameters for the different relaxations are given below and are in 
reasonable agreement with the literature values6: log τ∞ = -12.76, ΔEβ = 68 kJ/mol for βJG 
relaxation; log τ∞ = -14.64, ΔEγ = 48 kJ/mol for γ relaxation and log τ∞ = -9.52, ΔEδ = 
15 kJ/mol for δ relaxation.  
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Temperature dependence of secondary relaxations in indomethacin. Due to the weak βJG 
relaxation signal in indomethacin, its temperature dependence could not be ascertained. 
The βJG relaxation time is sensitive to pressure56 while the temperature dependence of βJG 
relaxation time remains unaffected by pressure as observed in sorbitol and xylitol57,58. 
The extent of correlation between the relaxation time and crystallization time depends on 
the temperature dependence rather than the absolute relaxation times. Therefore, we used 
the literature data for temperature dependence of βJG relaxation time in indomethacin, 
obtained under high pressure59. The temperature dependence of γ- and δ- relaxation in 
glassy indomethacin could be reliably obtained (Figure 3.2b and 11). The fitted 
parameters are in excellent agreement with the literature values59: log τ∞ = -10.54, ΔEγ = 
38 kJ/mol for γ relaxation and log τ∞ = -13.69, ΔEδ = 38 kJ/mol for δ relaxation. 
Isothermal crystallization kinetics by XRD. Supercooled and glassy state. 
Crystallization occurred rapidly in the supercooled state and a laboratory source XRD 
was adequate to monitor crystallization kinetics. In the supercooled state, celecoxib 
crystallized as a mixture of forms I, II and III. As a representative example, the results 
obtained at 80 oC are presented in Figure 3.5a and a peak unique to each form is pointed 
out60. The characteristic peaks appeared after 40 min, and their intensity progressively 
increased until crystallization was complete. Figure 3.5b shows the fraction of celecoxib 
crystallized at different temperatures. The isothermal crystallization data was well 
described by the modified Johnson-Mehl61-Avrami62,63 (JMA) equation (eq 3.13):  
     (3.13) 
where α(t) is the fraction crystallized at any time t, αmax is the fraction crystallized at 
t→∞, αmin is the fraction crystallized at t→0 and in this case it is fixed at 0 since there is 
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no crystal growth at t = 0, k is the rate constant, to is the crystallization onset time and n is 
the reaction order. Since crystallization was not complete, αmax was obtained by fitting 
the model to the crystallization data. The time taken for 2.5% of the drug to crystallize, tc, 
was calculated from the fitted profile.  By carrying out the experiments at several 
temperatures, the temperature dependence of tc was obtained. Amorphous indomethacin 
was subjected to similar experiments. It crystallized in the α- and γ- forms in the 
supercooled and glassy states respectively (data not shown). For both indomethacin and 
celecoxib, the value of n (~ 1) remained constant in the temperature range studied. 
The enhanced sensitivity of the synchrotron source at the Argonne National Laboratories 
enabled us to measure low levels of crystallization in both glassy celecoxib and 
indomethacin. The characteristic crystallization time, tc, was taken as the time for 2.5% of 
the drug to crystallize (same as above Tg). Figure 6a contains representative SXRD 
patterns showing progressive drug crystallization in amorphous celecoxib at 45 oC. The 
2D patterns were integrated to obtain the 1D XRD patterns, and tc (Figure 3.6b). In the 
glassy state, only a mixture of forms II and III were observed. 
Correlation between molecular mobility and crystallization. Assuming that molecular 
mobility is responsible for the observed physical instability, we attempted to identify the 
specific mobility responsible for crystallization. We therefore investigated the correlation 
between molecular mobility and crystallization behavior in amorphous celecoxib and 
indomethacin. In order to enable a visual comparison, the temperature dependence of 
different relaxations and the characteristic crystallization time (tc, time taken for 2.5% 
crystallization) is plotted on the same graph (Figure 3.7). It is evident that crystallization 
in the glassy state is enhanced with respect to the prediction based on the extrapolation of 
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the data measured in the supercooled state. Similar results were reported by Ediger and 
Yu64,65. Above Tg, tc and structural relaxation time show a similar temperature 
dependence. On the other hand, in the glassy state, the temperature dependence of tc was 
markedly different from that of structural relaxation.  The structural relaxation time 
appears to plateau off at ~ (Tg - 14) and the weak signal did not permit measurements 
below this temperature. It will be interesting to investigate the temperature dependence of 
structural relaxation and crystallization at temperatures << Tg. In the temperature range 
investigated in the glassy state, tc and βJG relaxation time showed a parallel relationship 
(Figure 3.7). The similar temperature dependence indicates that these two processes are 
coupled in the glassy state. Similar results were observed in indomethacin (Figure 12). 
One possible explanation is that, in the supercooled state transport properties (viscosity, 
diffusion) contribute to the observed crystal growth. Hence, we see a substantial 
correlation with structural relaxation time (discussed in more detail in the next 
paragraph). However, nucleation in the glassy state has been attributed to molecular 
motions involved in the Johari-Goldstein relaxation66, a possible explanation for the 
observed correlation with the βJG relaxation time.  
In a log-log format, each regime (supercooled and glassy states) is well described by a 
linear relationship indicating a power law dependence of crystallization time (tc) with 
relaxation time67,68 (eq 3.14),  
    (3.14) 
wherein A is a constant and M is the value of the exponent. An exponent value of 1 
indicates that the processes are completely coupled. The crystallization time versus 
average structural relaxation time plot in the supercooled state was linear (Figure 3.8). 
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The exponent value was determined to be ~ 0.8 in both celecoxib and indomethacin, 
indicating substantial but not complete coupling between crystallization time and 
structural relaxation time measured by dielectric spectroscopy. Thus factors other than 
molecular mobility (measured as structural relaxation time) are likely playing a role in 
the crystallization process. The time for 2.5% of the drug to crystallize was arbitrarily 
chosen since crystallization is slow in the glassy state. For the sake of consistency, we 
used the same level of crystallinity for the correlation plots in the supercooled state. The 
choice of different levels of crystallinity did not seem to affect the coupling coefficient 
(Figure 3.13). We have characterized the dielectric response due to the dipole 
reorientation. In the context of this discussion, rotational and translational modes of 
motion are of interest. These two motions decouple between Tg and 1.2 Tg, the 
temperature range of our studies, due to the breakdown of the Stokes - Einstein 
relationship69. However, in this temperature range, while the rotational motions and 
viscosity remain coupled, the crystal growth rates scale with η-0.78. The translational 
diffusion coefficient and crystal growth rates exhibited the same temperature dependence 
in case of indomethacin, sorbitol and other small glass formers12,70. Since we did not 
observe complete coupling between rotational motions and crystallization time (M value 
of ~0.8; eq. 3.14), the physical stability in the temperature range of Tg to 1.2 Tg, may be 
better correlated to translational motions. Finally, we wanted to investigate if a specific 
molecular motion is coupled to the observed physical instability (crystallization) in the 
glassy state. We observed a poor correlation with the structural relaxation time (Figure 
3.9a and 9b; celecoxib: 0.3, indomethacin: 0.2). This may be a manifestation of the 
enhanced decoupling, of the translational and rotational motions, due to the spatially 
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heterogeneous dynamics in deeply supercooled (i.e. at temperatures slightly above Tg) 
liquids71. The faster motions (γ- and δ- relaxations) originate from intramolecular 
motions of certain functional groups in celecoxib72 and indomethacin. Therefore, their 
influence on physical instability is not considered significant.  Finally, we wanted to 
consider the influence of βJG relaxation on the crystallization process. In celecoxib, the 
βJG relaxation time could not be experimentally obtained in the temperature range where 
crystallization was monitored. Since the βJG relaxation exhibits an Arrhenius temperature 
dependence, we used the extrapolated relaxation times. Using equation 3.14, we observed 
a strong correlation between βJG -relaxation and the characteristic crystallization time in 
glassy celecoxib and indomethacin (Figure 3.9c,d; celecoxib: 1.4, indomethacin: 1.1). 
Although the value of the exponent is expected to be between 0 and 1, the higher values 
may be attributed to experimental errors.  
The β- relaxation process can be visualized as the motion of the entire molecule in these 
low density domains encaged by large cooperative regions which are relatively 
immobile29. It seems that the mobility in these local domains is sufficiently high to 
facilitate the right conformation to result in nucleation followed by growth.  According to 
Hikima et al73, the crystal-nucleation rate is determined by the  β-molecular 
rearrangement and not by the α- mobility mode. Recently, the physical stability of 
amorphous celecoxib has been indirectly linked to βJG relaxation72. The addition of 
octaacetylmaltose, while anti-plasticizing the βJG relaxation (in this context, 
antiplasticization refers to an increase in β-relaxation time) had no significant effect on Tg 
and enhanced physical stability. Sibik et al30 have also shown a strong correlation 
between fast dynamics and crystallization onset in several glass formers. In an exhaustive 
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study, a linear relationship between enzyme degradation rates and β- relaxation time in 
>100 plasticized (decrease in relaxation time) and antiplasticized sugar glasses was 
observed29. The degradation rate did not correlate with (T-Tg), a surrogate for structural 
relaxation time. The authors postulated that the anti-plasticization of fast motions caused 
stiffening of the glass matrix and decreased the degradation rate either by partial 
unfolding or reducing the exposure of highly reactive sites. In summary, our results 
reveal the strong influence of βJG relaxation on crystallization in glassy indomethacin and 
celecoxib. It will be interesting and useful to investigate such a correlation in a wide 
variety of glassy pharmaceuticals. Once established, such correlation models can 
potentially be used to predict physical stability at temperatures of interest. 
3.5 Conclusions 
 
In this work, dielectric spectroscopy was used to comprehensively characterize the 
different modes of molecular mobility in supercooled and glassy celecoxib and 
indomethacin. Isothermal crystallization studies were carried out using a laboratory X-ray 
diffractometer whereas synchrotron source enabled similar studies in the glassy state. The 
structural relaxation time was coupled to the characteristic crystallization time in the 
supercooled state. However, we did not observe a similar correlation in the glassy state. 
Interestingly, a stronger correlation was observed between the βJG relaxation time and 
physical instability in both glassy indomethacin and celecoxib.  While limited to only two 
compounds, this study provides an avenue to predict the physical stability (measured as 
crystallization) of glassy pharmaceuticals. Antiplasticization of the βJG relaxation can be 
a potential approach to enhance physical stability.  
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Figure 3-1 Dielectric compliance curves [ε(t)], where t is the duration of the voltage 
pulse, at different temperatures: (a) celecoxib and (b) indomethacin. The master curves 
were constructed with reference temperatures of 55 and 47°C for celecoxib and 
indomethacin respectively. For the sake of clarity, the master curve is offset by 3 decades 
for celecoxib and 4.5 decades for indomethacin.  
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Figure 3-2 Plots of temperature dependence of relaxations in (a) celecoxib and (b) 
indomethacin. The βJG values for indomethacin were obtained from the literature 
(reference 58). The black solid line describing the α-relaxation is the VFT fit obtained 
using eq. 3.9. The calorimetric Tg value is marked on the x-axis. 
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Figure 3-3 Plots of dielectric loss as a function of frequency in (a) celecoxib (at 60 °C) 
and (b) indomethacin (at 45 °C).  Following the fitting of α-relaxation, the excess wing 
becomes evident. Vertical arrows indicate the position of fo calculated using eq 3.11 
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Figure 3-4 Dielectric loss spectra over the temperature range of (a) 10 to 60 °C and (b) -
50 to -90 °C showing the presence of three secondary relaxations - βJG, γ and δ- in 
amorphous celecoxib. 
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Figure 3-5 (a) Representative XRD patterns of amorphous celecoxib from 0 to 240 min 
(at 80 °C), and (b) fraction of celecoxib crystallized as a function of time at different 
temperatures. The solid lines are the fits obtained using eq. 3.13. A peak unique to each 
polymorph is pointed out.  
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Figure 3-6 (a) Synchrotron XRD patterns of amorphous celecoxib at 45 °C as a function 
of time showing progressive crystallization, and (b) fraction of celecoxib crystallized as a 
function of time 
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Figure 3-7 Temperature dependence of average relaxation time (left y-axis) and 
characteristic crystallization time (in blue, right y-axis) for different mobility modes in 
amorphous celecoxib. The βJG -relaxation time was obtained by extrapolation since it 
shows an Arrhenius temperature dependence (Figure 3.2) 
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Figure 3-8 Plots of characteristic crystallization time (tc, time taken for 2.5% 
crystallization) versus average α-relaxation time above Tg (measured using time domain 
dielectric spectroscopy) in (a) celecoxib and (b) indomethacin. The α-relaxation time was 
obtained by extrapolating the VFT fit to the temperature range of interest. Error bars are 
provided when n=3; otherwise the crystallization time is the average of two 
determinations.  
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Figure 3-9 Plots of characteristic crystallization time (tc, time taken for 2.5% 
crystallization; interpolated from figure 7 and 12) versus relaxation time below Tg in 
celecoxib (a & c) and indomethacin (b & d). Note - For celecoxib, the βJG -relaxation 
time was obtained by extrapolation since it follows an Arrhenius temperature 
dependence. The βJG -relaxation time, in indomethacin, has been digitized from ref. 59.  
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Figure 3-10 DSC heating curves (10 °C/min) of amorphous celecoxib and indomethacin 
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Figure 3-11 Dielectric loss spectra over the temperature range of -75 to -20 °C showing 
the presence of two secondary relaxations - δ and γ- in amorphous indomethacin 
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Figure 3-12 Temperature dependence of average relaxation time (left y-axis) and 
characteristic crystallization time (in blue, right y-axis) for different mobility modes in 
amorphous indomethacin.  
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Figure 3-13 Plots of characteristic crystallization time (tc) versus relaxation time above Tg 
in (a) celecoxib and (b) indomethacin for different levels of crystallization. 
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Table 3.1 VFT parameters (eq 3.9) obtained from model fitting of the relaxation time data 
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4 Molecular Mobility In Glassy Dispersions: Physical Stability 
Implications  
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4.1 Introduction 
 
A large number of drug candidates under development suffer from the problem of 
aqueous insolubility. Among the numerous approaches, drug amorphization is an 
effective strategy to enhance the solubility and consequently the oral bioavailability of 
these new drug candidates. Solid dispersions, molecular drug − polymer mixtures, are 
known to physically stabilize amorphous drugs. However, the mechanism of stabilization 
by the polymer is not comprehensively understood. The role of thermodynamic and 
kinetic factors have been investigated in an effort to rationalize polymer selection1,2,3,4. 
The thermodynamic approach is of limited utility due to the typically low solubility of 
crystalline drugs in the polymers of interest5,6,7. Therefore, even at modest drug loading 
in a dispersion, the active pharmaceutical ingredient (API) is likely to be in a 
supersaturated state. Under such circumstances, crystallization inhibition is attributed to 
kinetic stabilization.  
Molecular mobility can serve as a potential predictor of physical stability, in both 
amorphous drugs and their dispersions8,9,10. In the supercooled state, structural relaxation 
time (a measure of molecular mobility) was found to correlate with the crystallization 
time in nifedipine11 (NIF) and itraconazole10 solid dispersions. Drug-polymer 
interactions, by modulating molecular mobility, influence the physical stability of 
amorphous solid dispersions (ASDs)12,13. The hydrogen bonding interaction of NIF with 
poly(vinyl) pyrrolidone (PVP) was much stronger than with hydroxypropyl 
methylcellulose acetate succinate (HPMCAS). As a result, the reduction in molecular 
mobility was more pronounced in PVP dispersions leading to enhanced physical 
stability8. In ketoconazole ASDs prepared with different polymers, the strength of 
 82 
 
interaction, the reduction in molecular mobility and crystallization inhibition followed the 
order: ionic > hydrogen bonding > dipole-dipole interaction14. Therefore, for preparing 
stable amorphous dispersions, molecular mobility can serve as a polymer selection tool. 
However, most of these studies were carried out in the supercooled state, i.e., at 
temperatures greater than the glass transition temperature Tg, rather than in the glassy 
state itself. The relationship between mobility and stability below Tg is warranted since 
ASDs are typically stored as glasses (T < Tg). In this work, we have investigated the 
structural relaxation behavior of glassy NIF dispersions prepared by mixing with either 
PVP or HPMCAS at different concentrations. As observed in the supercooled state8, the 
strength of hydrogen bonding, structural relaxation time and crystallization followed the 
same order: NIF - PVP > NIF - HPMCAS > NIF. Thus the mechanism of physical 
stabilization in the glassy and supercooled states seems to be the same for these systems.  
When the drug dose is high, ideally, the polymer should be effective at a low 
concentration so that the ‘pill burden’ is reasonable. Therefore, once a suitable polymer is 
selected, it is of immense practical interest to determine the minimum polymer 
concentration required to physically stabilize the drug during manufacture and storage. 
Previous work from our laboratory effectively employed molecular mobility as a tool to 
predict NIF crystallization in solid dispersions15 (described later). Based on the observed 
crystallization kinetics in ASDs with low polymer concentration, the model enabled 
prediction of crystallization behavior at higher polymer concentrations. All of these 
investigations were carried out in the supercooled state. In order to extend this approach 
to the glassy state, it is necessary to directly measure the structural relaxation time 
(typically > 102 s). The time-temperature superposition (TTS) principle has been used to 
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obtain the relaxation time in pharmaceuticals16,17,18,19 and  polymers20,21. We hypothesize 
that this principle would be valid in ASDs and allow the calculation of temperature 
dependence of structural relaxation time in glassy dispersions. Interference from the β-
relaxation can result in the potential breakdown of TTS22,23,24,25,26. This is often not 
readily evident in viscoelastic measurements because of their narrow dynamic range20. 
However, since dielectric spectroscopy covers a wide dynamic range, both α- and β- 
relaxations are more readily observed. In this work we have used dielectric spectroscopy, 
to perform TTS in NIF dispersions. We also evaluated the validity of time-temperature-
concentration superposition. This provided a relationship between structural relaxation 
time and polymer concentration in the solid dispersions. To the best of our knowledge, 
this is the first application of the TTS principle to characterize structural relaxation in 
glassy dispersions. Secondly, the time-temperature-concentration superposition provides 
an avenue to predict the effect of polymer concentration on molecular mobility and, by 
extension, on the physical stability. 
4.2 Experimental section 
 
Materials. NIF (C17H18N2O6; Laborate Pharmaceutical Ltd, India), PVP (K12 grade; Mw 
~ 2000 - 3000 g mol-1; BASF, USA) and HPMCAS - HF (Mw ~ 18000 g mol
-1 ; Shin-
Etsu Chemicals, Japan) were used as received.  
Preparation of amorphous drug and solid dispersions. Amorphous NIF was prepared 
by melting the crystalline powder and then quenching on an aluminum block precooled 
 to -20 °C. The NIF dispersions were prepared by solvent evaporation followed by melt-
quenching. For each polymer system, a physical mixture of NIF and polymer was 
dissolved in an appropriate solvent (acetone, methanol or dichloromethane). The solvent 
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was evaporated at 40 °C under reduced pressure in a rotary evaporator (IKA-HB10, 
Werke GmbH and Co., Germany). The samples were dried overnight, at room 
temperature, to remove excess solvent. PVP solid dispersions contained between 10 and 
20% w/w polymer while the HPMCAS concentration was kept at 10% w/w.  The powder 
was then heated to 5 °C above the melting point of NIF and quenched to -20 oC. The melt 
was lightly crushed using a mortar and pestle in a glove box at room temperature (< 5% 
relative humidity). The powders were stored at -20 °C in desiccators containing 
anhydrous calcium sulfate until further use. The films were prepared in a similar manner 
by melting the powder between the two electrodes (sample assembly of the dielectric 
spectrometer) followed by quench cooling.  
Differential Scanning Calorimetry. A differential scanning calorimeter (Q2000, TA 
Instruments, New Castle, DE) equipped with a refrigerated cooling accessory was used. 
The instrument was calibrated with tin (SRM 741a, NIST). In a glovebox, accurately 
weighed samples were hermetically sealed in aluminum pans. All the measurements were 
done under dry nitrogen purge (50 ml/min) at a heating rate of 10 oC/min following a 
cooling step at the same rate. 
Synchrotron XRD (SXRD; transmission mode). The enhanced sensitivity of the 
technique enabled us to monitor low levels of crystallization in select systems. Powdered 
samples were hermetically crimped in DSC pans and exposed to synchrotron radiation. 
Experiments were performed in the transmission mode in the 17-BM-B beamline at 
Argonne National Laboratory (Argonne, IL, USA). A monochromatic X-ray beam 
[wavelength 0.75009 Å; beam size 250 μm (horizontal) × 160 μm (vertical)] and a two-
dimensional area detector (XRD-1621, PerkinElmer) was used. Calibration was 
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performed using an Al2O3 standard (SRM 674a, NIST). Using a stepper motor, the 
sample was continuously moved (±1 mm from the center along the horizontal axis) 
during data collection. Each sample was scanned at 30 points, with an exposure time of 1 
s for each scan (2 mm/30 seconds), and the results were averaged. 
Dielectric spectroscopy. The structural relaxation time was obtained using an in-house 
built time domain dielectric spectrometer27,28. For measurements in the supercooled state, 
the film sample was heated from room temperature to the temperature of interest, after 
the temperature stabilized (± 0.2 oC), the voltage bias (200 V for 100 s) was applied. This 
was repeated at several temperatures above Tg.  The measurements below Tg were carried 
out in “minimally aged glasses”, i.e., the dielectric measurements in the glassy state were 
carried out isochronally at a constant aging time (in this case 1020 seconds)29. The 
sample was first heated to (Tg + 10 
oC) to remove the effect of thermal history and then 
cooled to the desired measurement temperature. In order to ensure that the dielectric 
probe is not influenced by the ongoing structural recovery, the measurement time (in this 
case 100 seconds) was less than 10% of the aging time30.   
4.3 Data analysis 
 
Dielectric response data. The dielectric compliance behavior is often well represented 
by the modified Kohlrausch31-William-Watts32 equation (KWW) (eq 4.1)28, which 
includes the conductivity contribution.  
    (4.1) 
where ε1 is the zero time dielectric compliance, (ε1 + ε2) is the long time plateau 
compliance, β is related to the breadth of the relaxation spectrum, τ and τc are the 
relaxation and conductivity times respectively. Our previous study showed that, in the 
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temperature range of 31 to 62.5 oC, the time-aging time33 and time-temperature34 
superpositions hold true in NIF17. 
Time-temperature and time-concentration superposition. The superposition principle 
is based on the assumption that the shape of the response curve (permittivity versus log 
time in this case) is independent of temperature or concentration. Thus, the curves can be 
shifted horizontally to a reference curve thereby constructing a master curve in reduced 
time (tred).   
         (4.2) 
where a(i) is the horizontal shift factor and is determined by 
         (4.3) 
In eq (4.3) i can represent either temperature (T) or concentration and τ(i)r is the reference 
relaxation time. Instead of using the KWW equation to fit each curve, and then estimating 
τ(i) and a(i), the master curve was constructed by manual shifting. First a reference curve 
was selected and then the rest of the profiles, obtained at different temperatures, were 
superimposed on the reference curve by shifting along the time axis. The τ(i) was then 
determined as  
  (4.4) 
The curves superimposed very well except at short and long times (Figure 4.1). At short 
times, this observation is attributed to the appearance of a weak β-relaxation. The lack of 
superposition at longer time scales is due to interference from dc conductivity. Only the 
data ascribed to the structural relaxation, separated from the β-relaxation, was considered 
in this calculation. 
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4.4 Results and discussion 
 
Characterization of PVP and HPMCAS dispersions 
Glass transition temperature. The calorimetric Tg  (Tg,cal) values of NIF and the 
dispersions (10% w/w polymer) prepared with each PVP and HPMCAS were 45.7 ± 0.2, 
46.2 ± 0.2 and 46.7 ± 0.2 °C respectively. The calorimetric Tg values were almost 
identical despite differences in their relaxation times (discussed later). The Tg values 
calculated using the Gordon - Taylor equation35 (eq 4.5) for NIF - PVP and NIF - 
HPMCAS dispersions were 48.3 and 48.9 °C respectively [reported density (g/cm3) 
values used for calculation: NIF (1.36)36, PVP (1.23)37, HPMCAS (1.29)4].  
      (4.5) 
In this equation, w is the weight fraction and the value of K is given by ρ1Tg,1 / ρ2Tg,2 38. 
The free volume additivity does not hold and the experimental Tg values were lower than 
those predicted using ideal mixing. The negative deviation can be attributed to a net loss 
in the degree of hydrogen bonding on mixing the two components39.  
Structural relaxation time. Dielectric spectroscopy was used to characterize the 
structural relaxation, both in the supercooled and glassy states. With an increase in 
temperature, the observed shift in the dielectric response curves can be ascribed to a 
decrease in relaxation time   (Figure 4.1).  The sharp increase in permittivity after the 
secondary plateau is attributed to dc conductivity40,41. The addition of the polymers 
caused a pronounced increase in conductivity, an effect attributable to ionic impurities in 
the polymers.  
The effect exerted by PVP and HPMCAS on the molecular mobility is evident from the 
dielectric profiles shown in Figure 4.2. The rise in permittivity (ε), reflecting dipole 
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alignment, was most pronounced in NIF while NIF - HPMCAS and NIF – PVP showed 
similar and weaker increase in ε than pure NIF at long times.  The time taken to reach the 
secondary plateau appears to increase in the following order: NIF < NIF - HPMCAS < 
NIF - PVP. That is, the dipoles seem to take slightly longer to orient in the NIF - PVP 
than in the corresponding HPMCAS dispersions. These observations indicate that the 
molecular mobility increases in the following order: NIF - PVP < NIF - HPMCAS < NIF 
(Figure 4.3).  Though the differences between the NIF-PVP and NIF-HPMCAS systems 
do not appear very large in Figure 4.2, the quantitative analysis of the retardation times in 
Figure 4.3 shows this ordering clearly above the glass transition (Figure 4.3a), while the 
NIF and NIF-HPMCAS seem similar in the glassy state (Figure 4.3b). 
At the selected “reference temperature”, the relaxation time (τ) and shape parameter 
(βKWW) were obtained using the modified KWW equation (eq 4.1). Assuming β remains 
constant, the relaxation times at the other temperatures of interest were calculated using 
the TTS principle. The relaxation time distribution is slightly broader in dispersions 
(βKWW of 0.5 and 0.6 for PVP and HPMCAS dispersions respectively) as compared to 
NIF (0.7).  The relative broadening of the segmental relaxation peak in polymer blends 
has been correlated to their ΔTg values (difference between the Tg values of drug and 
polymer) i.e. the peak becomes broader as the ΔTg increases (ΔTg = 44 and 76 °C for the 
PVP and HPMCAS dispersion respectively)42. This effect can be attributed to the 
significant difference in mobility between the two components.  
The average relaxation time, in the glassy and supercooled states, could be rank ordered 
as NIF - PVP > NIF - HPMCAS > NIF (Figure 4.3). The time-temperature superposition 
(TTS) principle described earlier was used to calculate the relaxation time. Kothari et al8 
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observed a similar trend in these systems in the supercooled state. The temperature 
dependence in the supercooled state was non-linear and well described by the Vogel43 - 
Fulcher44 - Tamman45 (VFT) model (eq 4.6) 
             (4.6) 
where T is the temperature, τo is the relaxation time of the unrestricted material (10-14 s, 
the quasi-lattice vibration period46), D is the strength parameter, and To is the temperature 
of zero mobility (theoretical Kauzmann temperature). Table 4.1 contains the parameters 
obtained by fitting the VFT model to the data and are in agreement with the literature 
values8.  The low strength parameter (D) values are indicative of a fragile glass former. 
The fragility index47,48, m, is related to D by eq 747 and the calculated values are provided 
in Table 4.1  
            (4.7) 
The addition of polymer, at 10% w/w, does not seem to influence the fragility measures 
(m and D values) of the systems. This is perhaps not surprising since there was only a 
small change in the Tg values
49. The calculated dielectric Tg, assuming a relaxation time 
of 100 s, typically exceeds the calorimetric Tg by 2 to 3 degrees
50 and a similar behavior 
is exhibited by these systems. Unless otherwise mentioned, any reference to glass 
transition temperatures will implicitly assume Tg,cal values.   
Physical stability. To study the influence of polymer type on the physical stability in the 
glassy state, the systems were held isothermally at 45 °C, and the crystallization was 
monitored using synchrotron radiation. PVP was more effective than HPMCAS in 
inhibiting NIF crystallization.  After 21 days of storage, crystallization, based on 
appearance of Debye rings, was observed only in the HPMCAS dispersion and not in the 
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PVP dispersions (Figure 4.4). On the other hand, NIF (in the absence of polymer) showed 
substantial crystallization after 5 days. Thus the most pronounced crystallization 
inhibition was observed with PVP. These dispersions also showed the longest relaxation 
time (i.e. slowest mobility; Figure 4.3b). 
In supercooled dispersions, PVP, through hydrogen bonding interactions with NIF, 
decreased the mobility of the dispersion8. Similarly in the glassy state, the longer 
relaxation times observed in the PVP dispersion when compared to HPMCAS, can be 
attributed to its stronger interaction with NIF (Figure 4.3b). To our knowledge this is the 
first report of the link between molecular mobility, strength of drug-polymer interactions 
and physical stability in glassy dispersions.  
Effect of PVP concentration  
Glass transition. In the investigated PVP concentration range (10 - 20% w/w), DSC 
revealed a single Tg in agreement with literature reports of miscible dispersions
51. As 
expected, the Tg of the system increased with PVP concentration (Figure 4.5).  The 
system exhibited a negative deviation from the Tg values predicted by the Gordon - 
Taylor equation35 (eq 4.5). This has been attributed to the stronger drug-polymer 
interactions compared to the drug-drug hydrogen bonding interactions52. Similar behavior 
is seen in felodipine (a structural analogue of NIF) - PVP systems52. 
Structural relaxation behavior. Dielectric spectroscopy was used to study the effect of 
polymer concentration on structural relaxation behavior in the supercooled and glassy 
states. With an increase in polymer concentration the dielectric response curves shifted to 
the right, an effect ascribed to an increase in relaxation time (Figure 4.6).  The longer 
“lag time” is likely due to an increase in viscosity which causes the dipoles to take longer 
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to orient in the direction of the electric field. As shown earlier, a decrease in temperature 
showed a similar effect (Figure 4.1). At this point, it is also instructive to point out the 
effect of polymer concentration on the dielectric constant (Figure 4.1). A small decrease 
in the dielectric compliance value at the secondary plateau, indicative of the dielectric 
constant of the system, is observed with an increase in polymer concentration. This is 
attributed to the low dielectric constant of  PVP53. 
The TTS master curves for each system, referenced to a temperature at which τ = 1 s, are 
shown in Figure 4.7a. When we compare the dispersion profiles, only the master curve of 
the 20% w/w polymer dispersion, referenced to τ = 1 s, did not superimpose with the 
other dispersions (inset of Figure 4.7a). In this instance, we believe that the modified 
KWW function does not adequately describe the relaxation behavior at long time scales 
due to a pronounced conductivity contribution. As a result, the obtained relaxation times 
may be unreliable leading to a discrepancy in the superposition of master curves at the 
nominal 1 second Tg. We therefore manually shifted (along the time axis) the master 
curve for the 20% polymer system resulting in superposition with the master curves at the 
other polymer concentrations (Figure 4.7a). Thus, in the investigated polymer 
concentration range, time-temperature concentration superposition holds. However, the 
NIF master curve does not superimpose with that of the dispersions. This is not surprising 
since the dispersions, unlike the drug, are binary systems. While there are examples of 
polymer – small molecule/solvent mixtures exhibiting time-concentration 
superposition54,55, this is not universal56. The βKWW value also provides insight into the 
lack of superposition. With an increase in polymer concentration from 0 to 20% w/w, the 
βKWW value decreased from 0.6 to 0.4. The consequent “stretching” of the exponential 
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function can explain the lack of superposition.  The decrease in βKWW value, indicative of 
increased heterogeneity, can be attributed to concentration fluctuations57 resulting in 
nanodomains with different Tg values and consequently different relaxation times
42. 
Figure 4.7b contains the shift factors used to construct the master curves for the drug and 
the NIF - PVP dispersions shown in Figure 4.7a. The VFT model (eq 4.8), in the 
framework of the TTS principle, describes the temperature dependence of shift factors:  
     (4.8) 
where aT is the horizontal shift factor required to shift the curve at temperature (T) 
relative to the reference temperature (Tref) and B is a constant. The temperature 
dependence of the shift factor, and therefore the fragility of the system, appears to be 
unaffected over a PVP concentration range of 0 to 20% w/w. 
The temperature dependence of relaxation time (τ) obtained from the shift factors, 
spanning the supercooled and glassy states, is shown in Figure 4.8a. As expected, with an 
increase in polymer concentration, the relaxation times become longer (i.e. mobility 
decreases). At 43 °C (glassy state), there is a ~ two fold increase in relaxation time as the 
polymer concentration increases from 0 to 10% w/w. This effect is more dramatic (~ 80 
fold) at a higher polymer concentration (20% w/w). Similar findings have been reported 
in the supercooled state15.  
Influence of polymer concentration on physical stability in the glassy state. 
Synchrotron XRD enabled us to detect NIF crystallization in solid dispersions stored at 
45 °C (Figure 4.9). In the absence of polymer (drug alone), NIF crystallization was 
evident after 24 hours of storage.  The addition of polymer caused a pronounced 
stabilization. In dispersions containing 10% w/w polymer, following storage for 50 days, 
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drug crystallization was readily evident. In contrast, when the polymer concentration was 
increased to 25% w/w, no drug crystallization was observed. Thus, increasing polymer 
concentration has similar effects on structural relaxation behavior (Figure 4.1) and 
physical stability (Figure 4.9) - an increase in relaxation time and a delay in 
crystallization. 
In summary, at T < Tg, an increase in structural relaxation time was accompanied by an 
enhancement in physical stability. However, other factors may influence devitrification 
deep in the glassy state11,58. At ~ 50 °C below Tg, where the α-relaxation is thought to be 
insignificant, it has been suggested that the β-relaxation may control the crystallization 
process59.  At temperatures between Tg and (Tg - 35), Brian and Yu for example observed 
that the surface crystal growth rate of nifedipine correlated with the surface diffusion60. 
4.5 Significance.  
 
The widespread use of ASDs in solid dosage forms hinges on our ability to (i) retain the 
API in the amorphous state during the entire shelf-life of the product, and (ii) to identify 
the polymer concentration needed to yield a physically stable product. Drug 
crystallization, by the attendant solubility decrease, can adversely affect the product 
performance. It is well recognized that physical stability of the drug is likely to increase 
as a function of polymer concentration. However, practical considerations may limit the 
polymer concentration. As a result, identifying the optimum polymer concentration is of 
great practical importance.  
In a log-log format, a power law dependence of crystallization time (tc) with relaxation 
time (τ) is observed (eq 4.9). This relationship has been used to predict crystallization in 
amorphous drugs as well as their dispersions9,11,15. 
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    (9) 
where A is a constant and M is the exponent value. The exponent value provides a 
quantitative measure of the role of molecular mobility on crystallization behavior. 
Kothari et al15 observed a linear relationship between relaxation time (or crystallization 
time) and polymer concentration and hence assumed the exponent value to be 
independent over a polymer concentration range of 0 to 20% w/w. In supercooled 
dispersions, the crystallization times predicted using this approach were in excellent 
agreement with the experimental results. Since amorphous pharmaceuticals are typically 
stored below the glass transition temperature, extending this approach to glasses is of 
immense practical value. This is possible if: (i) molecular mobility and physical stability 
are coupled and (ii) the relationship between relaxation time (or crystallization time) and 
polymer concentration is linear15. While we observed a non-linear relationship between 
relaxation time and polymer concentration (Figure 8b), the link between mobility and 
crystallization needs to be established. Performing crystallization studies, especially at 
high polymer concentrations, is very time consuming and would be the subject of a future 
investigation. These preliminary studies serve as a starting point to test the feasibility of 
this approach in glassy pharmaceuticals. Our ultimate aim is to predict crystallization in 
dispersions with high polymer loading at temperatures of pharmaceutical interest.  
4.6 Conclusions 
 
Time domain dielectric spectroscopy enabled a comprehensive characterization of the 
structural relaxation in glassy solid dispersions. Strong drug - polymer hydrogen bonding 
interactions improved the physical stability (i.e. absence of crystallization) by reducing 
the molecular mobility in these systems. An increase in polymer concentration, by further 
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reducing molecular mobility, enhanced the physical stability. Thus, molecular mobility 
can serve as a potential polymer selection tool. Our next objective is to use molecular 
mobility as the basis to predict crystallization in glassy dispersions.  
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Figure 4-1 Dielectric compliance curves [ε(t)], where t is the duration of the voltage bias, 
at different temperatures in (a) NIF (b) NIF - HPMCAS dispersions and NIF - PVP 
dispersions containing (c) 10% (d) 15% (e) 17.5% and (f) 20% w/w polymer. For the 
sake of clarity, the master curve is offset by 3 decades (denoted by A).  
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Figure 4-2 Dielectric compliance curves obtained at 45 oC in NIF and its dispersions with 
each PVP and HPMCAS (at 10% w/w polymer loading). 
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Figure 4-3 Temperature dependence of relaxation time in (a) supercooled and (b) glassy 
state of NIF and its dispersions prepared with each PVP and HPMCAS at 10% w/w 
polymer loading. The calorimetric Tg of each system is marked on the x-axis. 
 99 
 
 
Figure 4-4 SXRD patterns of (a) NIF (day 5) (b) NIF – PVP (day 21) and (c) NIF – 
HPMCAS (day 21) solid dispersions at 45 °C 
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Figure 4-5 Calorimetric Tg  as a function of polymer concentration. 
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Figure 4-6 Dielectric compliance curves of NIF and its dispersions with 10%, 15%, 
17.5% and 20% w/w polymer loading at 45 oC  
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Figure 4-7 (a)  Overlay of the master curves, referenced to a T (τ = 1 s), of NIF and NIF – 
PVP dispersions with 10%, 15% and 17.5%. The master curve of 20% w/w polymer 
loading was manually shifted by 0.3 decades to superimpose with other curves. The inset 
shows the superposition of master curves without the manual shifting of the 20% w/w 
polymer loading master curve, and  (b) Temperature shift factors (aT) as a function of (T-
Tref) in NIF and NIF – PVP dispersions. 
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Figure 4-8 (a) Temperature dependence of relaxation time in NIF and NIF – PVP 
dispersions. The calorimetric Tg of each system is marked in the x-axis. The relaxation 
times, below the indicated calorimetric Tg, were obtained by performing isochronal 
dielectric measurements at an aging time of 1020 seconds. (b) Relaxation time as a 
function of polymer concentration at different temperatures in glassy NIF – PVP 
dispersions. The solid lines are drawn to assist in visualizing the trend. 
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Figure 4-9 Synchrotron XRD patterns of NIF (day 1) and NIF – PVP dispersions (day 50) 
stored at 45 °C. Peaks due to the sample holder are marked with *. 
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Table 4.1 VFT parameters (eq 4.6) obtained from model fitting of the relaxation time 
data. 
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5.1 Introduction 
  
Amorphous systems are typically characterized by a pronounced tendency to sorb water. 
Water, by increasing the free volume1, plasticizes the system leading to an increase in 
mobility. This can potentially increase the risk of physicochemical instability in 
amorphous materials2,3,4. Therefore, it is important to tightly control the water vapor 
pressure in the atmosphere. However, during the manufacture and storage of amorphous 
pharmaceuticals, there are practical limits to the extent to which the ambient water vapor 
pressure can be reduced. Thus, it is important to understand the role of sorbed water 
content on molecular mobility and consequently the crystallization behavior of 
amorphous pharmaceuticals.     
Water sorption has been shown to decrease the physical stability of both single and 
binary amorphous systems. The increase in water content accelerated crystallization in 
amorphous sucrose and glucose5. It was attributed to the decrease in viscosity leading to 
increased probability of nucleation followed by crystallization. In amorphous lactose, 
with increasing water sorption, there was a progressive decrease in the peak 
crystallization temperature6. With an increase in affinity to water (hygroscopicity), there 
was a reduction in the ability of a polymer to inhibit drug crystallization7.    
The influence of water on molecular mobility has been investigated by dielectric 
spectroscopy, nuclear magnetic resonance spectroscopy (NMR) and isothermal 
calorimetry8,9,10. In colyophilized sucrose-PVP mixtures, based on NMR, water sorption 
caused no change in molecular mobility either in the PVP side chain or 
pyranose/furanose ring in sucrose9.  On the other hand, in melt quenched nifedipine-
excipient mixtures, a small increase in mobility was observed as a function of water 
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content11. In amorphous indomethacin, an increase in water concentration  from ~1.2 to 
~2.3% w/w, resulted in a pronounced increase in mobility (measured by dielectric 
spectroscopy)8. Similar results were observed in amorphous glucose12. While these 
investigations have qualitatively evaluated the effect of water sorption on mobility, there 
is no quantitative and comprehensive investigation of the effect of water on molecular 
mobility and consequently, physical stability.  
The objectives of this study were to systematically vary the water content in a model 
amorphous system and determine the effects on (i) molecular mobility, and (ii) 
crystallization behavior. These investigations were conducted using nifedipine - 
polyvinylpyrrolidone vinyl acetate 64 (NIF - PVP) as a model solid dispersion. Our initial 
goal was to carry out a comprehensive investigation encompassing both the glassy and 
supercooled states. Unfortunately, the studies in the glassy state had to be discontinued 
since the crystallization was much too slow.  However, using griseofulvin as a model 
drug, we were able to study the influence of water on the crystallization behavior in the 
glassy state. Thus these results provide insight into the role of water in both the glassy 
and supercooled states.  
5.2 Experimental section 
 
Preparation of amorphous phases. The NIF - PVP dispersions were prepared, at 15% 
w/w polymer loading, by solvent evaporation followed by melt-quenching. The physical 
mixture was dissolved in methanol and the solvent was evaporated at 40 °C under 
reduced pressure in a rotary evaporator (IKA-HB10, Werke GmbH, Germany). In an 
effort to remove any residual solvent, the samples were dried overnight, at room 
temperature. The powder was heated to 5 °C above the melting point of nifedipine and 
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quenched to -20 oC. The melt was lightly crushed using a mortar and pestle in a glove 
box at room temperature (< 5% relative humidity). Amorphous griseofulvin was prepared 
by melting the crystalline powder and then quenching on an aluminum block precooled 
 to -20 °C. The powders were stored at -20 °C in desiccators containing anhydrous 
calcium sulfate until further use. The water contents of the dispersion and the amorphous 
griseofulvin were consistently < 0.2 and 0.4% w/w respectively. The ‘as prepared’ 
amorphous phases are hereafter referred to as ‘dry’ dispersion or griseofulvin. 
Samples containing sorbed water. NIF - PVP dispersions containing 0.6, 0.9 and 1.5% 
w/w water were prepared by storing in chambers maintained at 32.8, 52.8 and 75.3% RH 
(25 °C) for two hours. Amorphous griseofulvin sorbed 0.75% w/w water when stored at 
75.3% RH (25 °C) for one hour. The desired RH values were obtained using saturated 
salt solutions13. 
Karl Fischer Titrimetry. The water content was determined coulometrically using a 
Karl Fischer titrimeter (DL36, Mettler Toledo, Columbus, OH). Approximately 50 - 100 
mg of the powdered sample was added to the titration cell and the water content was 
determined.  
Differential Scanning Calorimetry. A differential scanning calorimeter (Q2000, TA 
Instruments, New Castle, DE) equipped with a refrigerated cooling accessory was used. 
The instrument was calibrated with tin (SRM 741a, NIST). Accurately weighed sample 
was hermetically sealed in aluminum pans. All the measurements were done under dry 
nitrogen purge (50 ml/min) at a heating and a cooling rate of 10 °C/min. The Tg was 
determined as the midpoint of the temperature range of the transition.  
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X-ray diffractometry (XRD). A powder X-ray diffractometer (D8 ADVANCE; Bruker 
AXS, Madison, WI, USA) equipped with a variable temperature stage (TTK 450; Anton 
Paar, Graz-Straßgang, Austria) and Si strip one-dimensional detector (LynxEye™; 
Bruker AXS) was used. The powder samples were exposed to Cu Kα radiation (40 kV & 
40 mA), and the diffraction patterns were obtained by scanning over an angular range of 
5 to 40° 2θ with a step size of 0.05° and a dwell time of 1 s. 
Synchrotron XRD (SXRD; transmission mode).  For the isothermal crystallization 
studies, amorphous griseofulvin samples, either dry or containing 0.75% w/w water, were 
sealed in Mylar pouches and stored at selected temperatures. The samples, retrieved at 
selected time points, were hermetically crimped in DSC pans and exposed to synchrotron 
radiation. Experiments were performed in the transmission mode in the 17-BM-B 
beamline at Argonne National Laboratory (Argonne, IL, USA). A monochromatic X-ray 
beam [wavelength 0.72910 Å; beam size 250 μm (horizontal) × 160 μm (vertical)] and a 
two-dimensional area detector (XRD-1621, PerkinElmer) were used. Calibration was 
performed using an Al2O3 standard (SRM 674a, NIST). The synchrotron experiments 
were conducted at room temperature. The two-dimensional (2D) data were integrated to 
yield 1D d-spacing (Å) or 2θ (°) scans using the FIT2D software developed by A. P. 
Hammersley of the European Synchrotron Radiation Facility14,15  
Quantification of XRD data. At each time point, crystallinity index was calculated 
using eq 1. The crystallinity index can be considered equivalent to the % crystallinity, if 
the total integrated intensity (amorphous + crystalline) remains constant throughout the 
isothermal crystallization experiment16.  
        (5.1) 
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To quantify the crystallinity index, a custom-built program (using Fortran 77) was used. 
In this program, the amorphous intensity contribution was based on the experimental 
XRD pattern of the amorphous “reference” material. The subtraction of the amorphous 
intensity from the total pattern yielded the intensity contribution from the crystalline 
peaks. The percent crystallinity was plotted as a function of time, and a characteristic 
crystallization time (tc) was obtained for a desired level of crystallization (0.5% in this 
study). 
Dielectric spectroscopy (DES). A broadband dielectric spectrometer (Novocontrol 
Alpha-AK high performance frequency analyzer, Novocontrol Technologies, Germany) 
was used over a frequency range of 10-2 to 107 Hz. About 100 mg of powder sample was 
placed between two round copper electrodes (20 mm diameter) and a PTFE spacer. The 
PTFE spacer (thickness, 1 mm; area, 59.69 mm2; and capacitance, 1.036 pF) was used to 
keep the sample confined between electrodes at high temperatures and also to minimize 
errors due to stray capacitance or edge effects. Powdered samples containing sorbed 
water were sealed between electrodes using Permatex® High-Temp Red RTV Silicone to 
retain the water during the dielectric measurement. The water content determined, before 
and after the dielectric measurement, did not reveal any difference.  
The Havriliak-Negami function (eq 5.2) was used to fit the dielectric data to obtain the 
average relaxation time (τ) and the shape parameters (αHN and βHN).  
         (5.2) 
              (5.3) 
In eq 5.2, ω is the angular frequency, ε*(ω) is the complex dielectric permittivity (eq 5.3) 
consisting of real (ε’) and imaginary components (ε”) and Δε is the dielectric strength 
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given by Δε = εs - ε∞ where εs, static permittivity, gives the low frequency limit (ω→0) of 
ε’(ω) and ε∞ gives the high frequency limit (ω→∞) of ε’(ω). The shape parameters (αHN 
and βHN) account for the symmetric and asymmetric broadening of the spectrum 
respectively, and 0 < α (or β) < 1.  
 
5.3 Results 
 
NIF – PVP dispersion 
Baseline characterization.  The dispersion was observed to be X-ray amorphous both 
before and after water sorption. As expected, with increasing water content, there was a 
progressive decrease in the glass transition temperature (Tg) of the NIF - PVP dispersions 
(Figure 5.1a).   
Effect of water content on molecular mobility in supercooled dispersions. Dielectric 
spectroscopy was used to characterize the molecular mobility in ASDs containing 
different amounts of sorbed water. In the dry dispersions, isothermal frequency sweeps 
were conducted at several temperatures ranging from 40 to 90 oC.  In systems containing 
water, the experiments were conducted only over a temperature range of 30 to 60 oC to 
minimize water loss during measurement. In the supercooled state, irrespective of the 
water content, well resolved α-relaxation peaks were observed (Figure 5.2). This mobility 
mode, also referred to as global motion, is cooperative in nature and responsible for glass 
transition. As the temperature was increased, the peak moved to a higher frequency 
indicating a decrease in the relaxation time i.e. an increase in the global mobility of the 
system. At a given temperature, the effect of water on molecular mobility was evident 
from the position of the dielectric loss peak (Figure 5.1b). At a modest water content of 
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1.5% w/w, when compared with the spectrum of the dry sample, the dielectric loss peak 
exhibited a pronounced shift to a higher frequency, indicating a pronounced increased in 
molecular mobility. In Figure 5.2d, an additional loss peak at low frequency is observed 
at elevated temperatures. This is attributed to the interfacial polarization, known as the 
Maxwell-Wagner polarization17,18.  
The α-relaxation times (τ) were obtained by fitting the Havriliak - Negami equation 
(eq 5.2) to the dielectric loss data. Figure 5.3a shows the temperature dependence of 
relaxation time in NIF – PVP dispersion with increasing water content.  Addition of 0.6% 
and 1.5% w/w water resulted, respectively, in approximately 1.5 and 3 orders of 
magnitude decrease in relaxation time. The temperature dependence was non-linear and 
well described by the Vogel19 - Fulcher20 - Tamman21 (VFT) model (eq 5.4): 
             (5.4) 
In eq 5.4, τ is the relaxation time at temperature T, τo is the relaxation time of the 
unrestricted material (10-14 s, the quasi-lattice vibration period22), D is the strength 
parameter and To is the zero mobility temperature. The VFT parameters are provided in 
Table 5.1. The strength parameter (D value)19,20,21, irrespective of the water content, was 
~ 8, indicative of a fragile glass former. Sorbed water content, up to 1.5% w/w, does not 
seem to influence the fragility of the dispersion. The plots of relaxation time versus Tg /T 
are shown in Figure 5.3b. Here, Tg is defined as the temperature at which τ = 100 
seconds. The temperature scaling (Tg/T) allowed us to simultaneously evaluate the effects 
of water content and temperature on the relaxation time. It is evident that once scaled, the 
relaxation times of the systems with different water contents overlap. This implies that 
the observed increase in mobility can be simply explained by the “plasticization” effect 
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of water. This is in agreement with the results obtained with several other 
compounds8,23,24.  However, over a wider concentration range, water may influence the 
fragility of the system25,26.  
Influence of water content on the crystallization behavior of supercooled dispersion. 
We had earlier reported that, with increasing water content, there was a progressive 
lowering in Tg (Figure 5.1a). DSC (Figure 5.4) revealed that this was accompanied by a 
decrease in crystallization onset temperature (Tc). The depression in Tg, due to the 
plasticizing effect of water, is known to accelerate crystallization6,27. With increasing 
water content, there was a progressive lowering of the melting point (Tm) (Figure 5.4). 
This can be explained by the melting point depression of the polymer brought about by 
diluent28.  It is attributed to the decrease in chemical potential of the melt phase through 
entropy of mixing29. Similar results have been reported in polymer-solvent28,30 and API-
polymer systems31.  Zhou et al32 introduced the concept of reduced temperature, (Tc - 
Tg)/(Tm - Tg), which provides an estimate of the crystallization tendency in the 
supercooled state. This value allows a comparison of crystallization propensities of 
compounds with different Tg and Tm values (Table 5.2). The lower the value, stronger is 
the crystallization propensity.  The reduced temperature value seemed to be unaffected by 
the water content. Thus a decrease in crystallization onset temperature can be explained 
by depression in Tg brought about by water. Similar findings have been reported in 
amorphous disaccharides3,27,4.  
In summary, in the supercooled state, water content, in a concentration dependent 
manner, increases the mobility and accelerates crystallization - effects attributable to 
plasticization. 
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Amorphous griseofulvin 
Baseline characterization.  Griseofulvin was observed to be X-ray amorphous both 
before and after water sorption. Dry amorphous griseofulvin was characterized by a Tg of 
89 oC, while sorption of  0.75% w/w water reduced the Tg to 75 
oC. 
Sorbed water – effect on crystallization of glassy griseofulvin. The crystallization 
behavior of dry powder was compared with a sample containing 0.75% w/w sorbed 
water. The studies were conducted at several temperatures, ranging from 25 to 45 oC. 
Irrespective of the storage temperature, sorbed water accelerated crystallization as is 
evident from the earlier appearance and the increase in intensity of the Debye rings 
(Figure 5.5). When crystallization was monitored as a function of time, at 45 oC, again 
the crystallization was substantially accelerated in presence of water (Figure 5.6). The 
time taken for 0.5% of griseofulvin to crystallize, tc, was determined at several 
temperatures. The temperature dependence of tc showed an Arrhenius relationship 
(Figure 5.7a).  
The temperature scaling (Tg /T) allowed us to simultaneously evaluate the effects of 
water content and temperature on the crystallization behavior. A single linear relationship 
explained the temperature dependence of tc in both the dry powder and in griseofulvin 
containing 0.75% w/w water (Figure 5.7b). This implies that the observed decrease in tc 
can be explained by the “plasticization” effect of water.  We had earlier observed the 
same effect of water in the supercooled state (Table 5.2).  The linear profile also indicates 
that the activation energy of crystallization is unaffected in the presence of water. Similar 
results have been reported in lamotrigine mesylate27 and in a proprietary spray dried 
dispersion4.  
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To summarize the results, in supercooled nifedipine dispersions containing sorbed water, 
both the mobility and crystallization onset temperature were observed to scale with Tg.. 
Similarly, in glassy griseofulvin, the plasticization effect of water could explain the 
decrease in crystallization time. Unfortunately, our efforts to determine the molecular 
mobility of the griseofulvin with sorbed water were not successful.   This was due to the 
difficulty in retaining the sorbed water during the dielectric measurement.  
Effect of water content on molecular mobility in the glassy state. While a direct 
measurement of molecular mobility in griseofulvin would have been ideal, based on 
literature, we expect the mobility to scale with Tg. In both indomethacin and in poly-L-
asparagine, D (a measure of kinetic fragility) remained unchanged in presence of 
water23,24. We obtained similar results in the NIF-PVP dispersion (Figure 5.3b).  The 
fragility index, m, is related to D by eq 5.533 
            (5.5) 
The fragility or steepness index (m) is defined as the characteristic slope of the plot of log 
τ versus Tg/T, and at Tg, the slope is given by eq 5.633.   
     (5.6) 
In the glassy state, the temperature dependence of α-relaxation is often described by the 
Adam - Gibbs model34  
     (5.7) 
where Tf denotes fictive temperature and is defined as the temperature at which a non-
equilibrium property p (enthalpy or entropy) of a glass, in excess with respect to the 
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stable crystalline state, would have the same value as in the equilibrium supercooled 
liquid. Eq 5.7 can be rewritten as:  
  (5.8) 
where 
)   (5.9) 
In eq 5.9,  mmin is the lower limit of fragility and is ~ 16
33.  At low water content, since D 
is unaffected, To/Tg can be assumed to be constant. At temperatures close to Tg, Tf ≈ Tg 
and therefore To/Tf  ≈  To/Tg. Thus, eq 5.8 becomes 
  (5.10) 
where A is a constant 
  
Thus, we anticipate the data points in a plot of log τ vs Tg/T to overlap and therefore 
described by a single relationship4. Hence, mobility, along with crystallization time 
(shown earlier), is expected to scale with Tg in the glassy state. This has been observed in 
amorphous raffinose with different water contents (2.0 to 6.3% w/w)10. The relaxation 
times were close to one another, when plotted against (Tg – Ta) where Ta is the annealing 
temperature. These experiments were conducted over (Tg – Ta) spanning 50 degrees.  
However, the use of the Adam Gibbs model has limitations. In the literature, Tf is often 
assumed to be equal to Tg
35,36. This is only possible if the annealing temperature is very 
close to Tg or the heat capacity of the crystalline and the glassy states are very close. 
However, since the heat capacity of a glass is always higher than that of its crystalline 
counterpart, Tf < Tg.  The magnitude of this difference can be obtained by comprehensive 
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measurements in the glassy state.  In spite of these limitations, the Adam Gibbs model 
provides an avenue to estimate the effect of water on the mobility in the glassy state with 
experimental data obtained in the supercooled state.  
5.4 Significance.  
 
It is well known that amorphous systems have a strong tendency to sorb solvents 
including water. Thus it is very difficult to “completely dry” amorphous pharmaceuticals 
(drug substance as well as dispersions). Sorbed water, in a concentration dependent 
manner, caused a pronounced increase in molecular mobility. This increase, as well as the 
faster crystallization, could be completely explained by the plasticizing effect of water.  
Our results should be viewed with caution since they are qualitative and based on two 
model systems. The next step will be to systematically investigate the effect of 
plasticization on both mobility and stability in a single model system. While the 
correlation between mobility and stability has been established in “dry” systems37,38,39, 
we do not know the impact of sorbed water on this correlation.  
5.5 Conclusions 
 
The influence of sorbed water on the physical stability (crystallization) in a model drug 
(griseofulvin) and a dispersion (NIF - PVP) was investigated.  Water sorption led to a 
decrease in both the relaxation (increase in mobility) and crystallization times - effects 
attributed to “plasticization” by water.  
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Figure 5-1 The effect of water content on the (a) Tg (mean ± SD; n = 3) and (b) dielectric 
loss behavior of NIF-PVP dispersions at 50 oC. The arrows show the progressive shift in 
the loss peak, to higher frequencies, with increasing water content. 
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Figure 5-2 Dielectric loss spectra of NIF - PVP dispersion, (a) in the dry state and 
containing (b) 0.6%, (c) 0.9% and (d) 1.5% w/w water respectively. The loss curves have 
been normalized to the maximum loss value.  
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Figure 5-3 Plots of relaxation time (mean ± SD; n = 3) as a function of (a) inverse 
temperature, and (b) Tg/T in NIF-PVP dispersions.   
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Figure 5-4 DSC curves of NIF – PVP dispersion. The water content ranged from 0.6 to 
1.5% w/w. 
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Figure 5-5 Synchrotron XRD patterns of amorphous griseofulvin after 12 hours of 
storage at the indicated temperature.  (a) Dry powder and (b) sample containing 0.75% 
w/w water. 
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Figure 5-6 XRD patterns obtained following storage at 45 °C of (a) dry griseofulvin and 
(b) sample containing 0.75% w/w water. The 1D patterns were obtained by integrating 
the 2D synchrotron images. 
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Figure 5-7 Plot of crystallization time, tc, as a function of (a) inverse temperature, and (b) 
scaled temperature (Tg/T) in amorphous griseofulvin (mean ± relative error). The powder 
was either dry or contained 0.75% w/w water.  
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Table 5.1 VFT parameters for the NIF-PVP dispersions. The values were obtained from 
fitting eq. 5.4 to the relaxation time data. The dielectric and calorimetric Tg values are 
also tabulated. 
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Table 5.2 Non-isothermal crystallization behavior of NIF – PVP dispersion with different 
water contents  
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6 Accelerated stability testing method of amorphous dispersions 
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6.1 Introduction 
 
One of the major challenges in the development of amorphous formulations is the reliable 
prediction of long term physical stability. Studying degradation kinetics at elevated 
temperatures and extrapolating to room temperature, an approach classically used for 
predicting chemical stability, cannot be used for physical stability (crystallization) 
prediction. Molecular mobility has been used to build predictive models for 
crystallization in both dry amorphous drugs1,2,3 and dispersions4,5. This may not be 
practically feasible in systems with high polymer loading, since crystallization is 
extremely slow. It will therefore be useful to develop an accelerated stability (physical) 
testing method enabling crystallization prediction under practical storage conditions. 
Our goal, much like in chemical degradation studies, is to accelerate drug crystallization 
from amorphous dispersions. This can be accomplished by monitoring the properties 
following storage under elevated temperature or by increasing the water content in the 
dispersions.  Exposing the ASD to elevated temperatures is not a desirable approach for 
at least two reasons. (i) There is potential for chemical degradation, particularly if the 
temperature is substantially higher than room temperature. (ii) If the studies are 
conducted in the supercooled state (as is likely to be the case), extrapolation of the results 
to the glassy state may lead to erroneous conclusion. This is because of the discontinuity 
in the temperature dependence of the properties of interest. Water sorption decreases the 
Tg of the dispersion and can consequently facilitate crystallization
6. This plasticization 
effect of water allows the accelerated stability studies to be conducted at or close to room 
temperature.  
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The combined effects of temperature and sorbed water content on the crystallization 
behavior of amorphous pharmaceuticals have been investigated. Miyazaki et al studied 
the crystallization behavior of supercooled nilvadipine with  different water contents7. 
Irrespective of the water concentration, the plots of crystallization time vs Tg/T 
overlapped, attributable to the plasticizing effect of water. Similar results were observed 
in lamotrigine mesylate8 and in an amorphous solid dispersion9. In our earlier 
investigation, we evaluated the effect of water sorption on the molecular mobility in NIF 
dispersions. The increase in molecular mobility was explained by the plasticization effect 
of water. Interestingly the temperature dependence of the α-relaxation time was 
independent of the water content.  In several model systems, we have documented a 
correlation between molecular mobility and crystallization (both onset and kinetics) 
(reference). However, these studies were restricted to system with very negligible water 
content. Therefore, a logical extension will be to determine the influence of water content 
on the correlation between mobility and crystallization. We hypothesize that the extent of 
coupling between molecular mobility and crystallization time would remain unaffected in 
dispersions. If the hypothesis is valid, then the use of the coupling coefficient obtained 
from studying the stability of dispersions with different water contents can be used to 
predict crystallization in dry systems. If our approach is successful, this has the potential 
to predict the physical stability of dispersions and thereby reduce the time for solid 
dispersion development.      
6.2 Experimental section 
 
Preparation of amorphous solid dispersion. FEL (C18H19Cl2NO4) and PVP (K17 
grade) were used as received. The FEL - PVP solid dispersions were prepared, at 10% 
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w/w polymer loading, by solvent evaporation followed by melt-quenching. A physical 
mixture of drug and polymer was dissolved in methanol and the solvent was evaporated 
at 40 °C under reduced pressure in a rotary evaporator (IKA-HB10, Werke GmbH, 
Germany). The samples were dried overnight, at room temperature. The powder was 
heated to 150 °C (5 degrees above the melting point of felodipine) and immediately 
quenched to -20 oC and then transferred to a glove box at room temperature (< 5% 
relative humidity). The quenched sample was lightly crushed using a mortar and pestle 
and stored at −20 °C in desiccators containing anhydrous calcium sulfate. The water 
contents of the dispersion was consistently < 0.2 w/w. The ‘as prepared’ amorphous 
dispersion is hereafter referred to as ‘dry’ dispersion. 
Samples containing sorbed water. Solid dispersions containing 0.9, 1.5 and 1.8% w/w 
water were prepared by storing in chambers maintained at 32.8, 75.3 and 93.0% RH (25 
°C) for two hours. Chambers of desired RH were obtained using saturated salt 
solutions10. 
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Karl Fischer Titrimetry. The water content was determined coulometrically using a 
Karl Fischer titrimeter (DL36, Mettler Toledo, Columbus, OH). Approximately 50 - 100 
mg of the powdered sample was added to the titration cell and the water content was 
determined.  
Differential Scanning Calorimetry. A differential scanning calorimeter (Q2000, TA 
Instruments, New Castle, DE) equipped with a refrigerated cooling accessory was used. 
The instrument was calibrated with tin (SRM 741a, NIST). Accurately weighed powder 
was hermetically sealed in aluminum pans and heated (or cooled) at 10 °C/min under dry 
nitrogen purge (50 ml/min). The Tg was determined as the midpoint of the temperature 
range of the transition.  
Dielectric spectroscopy (DES). A broadband dielectric spectrometer (Novocontrol 
Alpha-AK high performance frequency analyzer, Novocontrol Technologies, Germany) 
was used over a frequency range of 10-2 to 107 Hz and between 40 and 60 °C. About 100 
mg of powder sample was placed between two round copper electrodes (20 mm 
diameter) and a PTFE spacer. The spacer (thickness, 1 mm; area, 59.69 mm2; and 
capacitance, 1.036 pF) was used to keep the sample confined between electrodes at high 
temperatures and also to minimize errors due to stray capacitance or edge effects. 
Powdered samples containing sorbed water were sealed between electrodes using a 
silicone gasket (Permatex® High-Temp Red RTV Silicone). There was no measurable 
difference in the water content determined, before and after the dielectric measurement.  
The Havriliak-Negami function (eq 6.1) was used to fit the dielectric data to obtain the 
average relaxation time (τ) and the shape parameters (αHN and βHN).  
         (6.1) 
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              (6.2) 
In eq 6.1, ω is the angular frequency, ε*(ω) is the complex dielectric permittivity (eq 6.2) 
consisting of real (ε’) and imaginary components (ε”) and Δε is the dielectric strength 
given by Δε = εs - ε∞ where εs, static permittivity, gives the low frequency limit (ω→0) of 
ε’(ω) and ε∞ gives the high frequency limit (ω→∞) of ε’(ω). The shape parameters (αHN 
and βHN) account for the symmetric and asymmetric broadening of the spectrum 
respectively, and 0 < α (or β) < 1.  
X-ray diffractometry (XRD). A powder X-ray diffractometer (D8 ADVANCE; Bruker 
AXS, Madison, WI, USA) equipped with a variable temperature stage (TTK 450; Anton 
Paar, Graz-Straßgang, Austria) and Si strip one-dimensional detector (LynxEye™; 
Bruker AXS) was used. The powder samples were exposed to Cu Kα radiation (40 kV & 
40 mA), and the diffraction patterns were obtained by scanning over an angular range of 
5 to 40° 2θ with a step size of 0.05° and a dwell time of 1 s. 
Synchrotron XRD (SXRD; transmission mode). Isothermal crystallization studies were 
carried out, in situ, in the beamline (17-BM-B) at Argonne National Laboratory 
(Argonne, IL, USA). The powder samples were hermetically sealed in DSC pans and 
placed in a specially designed temperature stage. A monochromatic X-ray beam 
[wavelength 0.72910 Å; beam size 250 μm (horizontal) × 160 μm (vertical)] and a two-
dimensional area detector (XRD-1621, PerkinElmer) were used. Calibration was 
performed using an Al2O3 standard (SRM 674a, NIST). The raw images were integrated 
to yield one dimensional d-spacing (Å) or 2θ (°) scans using the GSAS II software 
(developed by Brian H. Toby and Robert B. Von Dreele at Argonne National Labs)11.  
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Quantification of XRD data. At each time point, the crystallinity index was calculated 
using eq 6.3. The crystallinity index is equivalent to % crystallinity, if the total integrated 
intensity (amorphous + crystalline) remains constant throughout the isothermal 
crystallization experiment12.  
        (6.3) 
To quantify the crystallinity index, a custom-built program (using Fortran 77) was used. 
The subtraction of the amorphous intensity from the total pattern yielded the intensity 
contribution from the crystalline peaks. The amorphous intensity contribution was based 
on the experimentally obtained XRD of the amorphous FEL – PVP dispersion. The 
percent crystallinity was plotted as a function of time, and a characteristic crystallization 
time (tc) was obtained for a desired level of crystallization (1% in this study). 
6.3 Results and discussion 
 
Baseline characterization.  The FEL - PVP dispersions were found to be X-ray 
amorphous with a calorimetric Tg of 49.1 ± 0.2 °C. With an increase in water content, 
there was a progressive decrease in Tg. Sorption of 0.9, 1.5 and 1.8% w/w water 
decreased the Tg to 46.0 (± 0.4), 37.2 (± 0.3) and 31.9 °C respectively. The dispersions 
continued to be X-ray amorphous after water sorption.   
Influence of water content on molecular mobility. FEL - PVP dispersions, with 
different water contents, were subjected to dielectric spectroscopy. In order to avoid 
water loss during the experiment, the measurements were restricted to temperatures 
below 60 oC. The dielectric spectra revealed well resolved α-relaxation peaks (Figure 
6.1). This relaxation mode represents cooperative motions responsible for glass 
transition. With an increase in temperature or water content, the relaxation peak shifted to 
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higher frequency indicating a decrease in relaxation time i.e. an increase in molecular 
mobility (Figures 6.1 and 6.2). This was also accompanied by an increased contribution 
of dc conductivity to the low frequency region of the spectrum (Figure 6.1).   
To obtain the relaxation times (τ), the Havriliak - Negami equation (eq 6.1) was used to 
fit the dielectric profiles. Figure 6.3a shows the temperature dependence of relaxation 
time in FEL - PVP dispersion with different water contents. As expected, the α-relaxation 
exhibited a non-Arrhenius temperature dependence  and was well described by the 
Vogel13 - Fulcher14 - Tamman15 (VFT) model: 
             (6.4) 
In this expression, T is temperature, τo is the relaxation time of the unrestricted material 
(10-14 s, the quasi-lattice vibration period16), D (the strength parameter) is a measure of 
the kinetic fragility and To is the zero mobility temperature. The VFT parameters are 
provided in Table 6.1. The strength parameter (D)13,14,15 value was ~ 11, both in dry state 
and dispersions containing sorbed water, reflecting the fragile nature of the glass former.  
Figure 6.3b shows the relaxation time as a function of temperature  scaled for dielectric 
Tg (defined as the temperature at which τ = 100 seconds). The data spans ~ 3 orders of 
magnitude of relaxation time and covers the temperature domain where the Angell plot17 
exhibits a strong curvature typical of fragile liquids. Water contents up to 1.8% w/w, do 
not seem to influence the fragility of the FEL - PVP dispersion. This implies that the 
increase in mobility caused by water is explained by its “plasticization” effect. We 
reported similar results in NIF - PVP dispersions earlier in Chapter 5.  
Sorbed water - effect on crystallization. Our next objective was to study the influence 
of water content on the physical stability in the supercooled state. Above Tg, the 
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isothermal crystallization was carried out in the temperature range of Tg to  (Tg + 53). 
The effect of water content on the isothermal crystallization behavior is evident from 
Figure 6.4.  From the intensity of the Debye rings, it is readily apparent that the 
crystallinity increased as a function of water content. The 2D patterns were integrated to 
obtain the 1D XRD patterns, and the % crystallinity was calculated (equation 6.3). Figure 
6.5, a representative example,  is a plot of fraction of drug crystallized as a function of 
time. These experiments were carried out isothermally at several temperatures.  The time 
taken for 1% of the drug to crystallize, tc, was used as a measure of physical instability.  
A similar set of experiments carried out in dispersions with different water contents, This 
provided a measure of the effect of water content on the temperature dependence of tc  
(Figure 6.6).  Crystallization time, tc, shows an Arrhenius temperature dependence for 
different water contents. The crystallization time, tc, decreases as the temperature and 
water content increase. The slopes of the line appear parallel to each other implying 
activation energy remains unchanged at low water content. Similar results have been 
reported in amorphous drug8 and dispersions9,7. 
Correlation between molecular mobility and crystallization. The classical 
crystallization rate18, G(T), is given by 
                                                           (6.5)  
or often approximated by 
                                                                          (6.6) 
where D(T), η(T) is the temperature dependence of molecular diffusion and viscosity 
respectively. f(T) represents the nucleation/crystal growth free energy term. Eq 6.6 is 
used whenever D(T) is unavailable or is limited in scope. The temperature dependence of 
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D(T) and η(T) is only comparable at small supercooling18-19, due to the breakdown of the 
Stokes - Einstein relationship at large supercooling (between Tg and 1.2 Tg)
20.  As a 
result, pronounced enhancement of D over η is observed at temperatures close to Tg. The 
decoupling factor, ξ, between D and η is expressed as 
                                                                       (6.7) 
where τα is the α-relaxation time. η and τα can be used interchangeably since they exhibit 
a similar temperature dependence. The coupling model, based on eq 6.6 and 6.7, provides 
a relationship between crystallization time, tc, and the relaxation time, τ (eq 6.8) 
                                                          (6.8) 
wherein M is the exponent value and A is a constant. The constant, A, is related to the 
free energy term in eq 6.6 and is a measure of the thermodynamic barrier to 
crystallization. An M value of 1 indicates complete coupling between the two processes. 
The log-log plot of crystallization and relaxation time in dry dispersion was linear (Figure 
6.7). The exponent value, M, was determined to be 0.63 indicating partial coupling 
between the two processes. This is attributed to the decoupling between the translational 
and rotational motions in the temperature range of Tg to 1.2 Tg. Similar M value ~0.67 
was reported in nifedipine - PVP dispersions (nifedipine - structural analogue of 
felodipine)5. The relationship between crystallization time and relaxation time, in dry 
dispersions, could be expressed as  
                                           (6.9) 
Since both tc and τ showed a similar temperature dependence in the water content range 
studied, we expected the exponent value to remain unchanged in presence of water. 
Indeed, the M value remained approximately the same in dispersions containing sorbed 
 139 
 
water. We obtained an M value of 0.64 and 0.67 for dispersions containing 1.5% and 
1.8% w/w water respectively. The value of constant A decreases very slightly, at low 
water content, indicating a decrease in free energy barrier for crystallization. These 
studies show that the extent of coupling between crystallization and molecular mobility 
remains the same in presence of water.  
6.4 Significance 
 
ASD’s will find extensive use if their potential for crystallization can be successfully 
predicted. Molecular mobility is an effective predictor of drug crystallization, as shown in 
amorphous drugs1,2, and dispersions4,5. However, extending this approach to commercial 
ASD’s and developing a model relating the drug crystallization from solid dispersion to 
molecular mobility may be practically challenging. The reason is, extremely slow 
crystallization in timescales of interest due to high polymer loading and storage 
conditions - typically in the glassy state. In this study, we observed that the correlation 
between molecular mobility and crystallization remains approximately the same in 
dispersions, at low water contents. As a first step towards predicting crystallization, we 
propose the use of “water sorption” to accelerate crystallization in slow crystallizing 
systems (high polymer loading dispersions). Thereafter, measuring the molecular 
mobility in presence of water would enable us to determine the exponent value (M 
value). We can calculate the value of constant A in eq 6.8, by carrying out crystallization 
studies in dry dispersions at an elevated temperature (rapid crystallization). This would 
allow the use of “water sorption” to build a model to predict crystallization in slow 
crystallizing systems. Since most amorphous pharmaceuticals are stored below the Tg, it 
will be of great practical interest to extend this approach in the glassy state. Time domain 
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dielectric spectroscopy can be used to experimentally measure α-relaxation  or the Adam-
Gibbs2 model can be employed to estimate the relaxation time below Tg.  However, in the 
glassy state the contribution from the β-relaxation will also need to be considered.  
6.5 Conclusions 
 
An increase in water content led to a decrease in relaxation time and consequently the 
physical stability of FEL - PVP dispersions. A good correlation was observed between 
crystallization time and α-relaxation time (a measure of molecular mobility) in 
supercooled dispersions. The extent of coupling between the two processes remained the 
same at low water contents. This information can be exploited to employ “water 
sorption” as an approach to predict crystallization in systems that crystallize slowly in 
practical timescales of interest.  
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Figure 6-1 Dielectric loss spectra of FEL - PVP dispersion, (a) in the dry state and 
containing (b) 1.5%, and (c) 1.8% w/w water respectively. The loss curves have been 
normalized to the maximum loss value.  
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Figure 6-2 Dielectric loss spectra of FEL – PVP dispersion showing α-relaxation at 54 
°C. The arrows show the progressive shift in the loss peak, to higher frequencies, with 
increasing water content. 
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Figure 6-3 Plots of relaxation time (mean ± SD; n = 3) as a function of (a) inverse 
temperature, and (b) Tg/T in FEL-PVP dispersions.   
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Figure 6-4 Two dimensional synchrotron XRD patterns of FEL – PVP dispersion, (a) in 
the dry state and containing (b) 0.6% and (c) 1.8% w/w water respectively, after holding 
at 85 °C for 12 hours. 
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Figure 6-5 Representative plot of fraction of FEL crystallized from FEL – PVP 
dispersion, in the dry state, as a function of time at several temperatures 
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Figure 6-6 Plot of crystallization time, tc, as a function of temperature in FEL – PVP 
dispersion, (a) in the dry state and containing (b) 0.6%, (c) 1.5% and (c) 1.8% w/w water 
respectively.  
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Figure 6-7 Plot of log crystallization time versus log average relaxation time in FEL – 
PVP dispersion  
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Table 6.1 VFT parameters for the FEL - PVP dispersion with different water contents. 
The values were obtained from fitting eq. 6.4 to the relaxation time data. 
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7 Summary 
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Previous investigators from our laboratory have established a  correlation between 
structural relaxation time and crystallization behavior in the supercooled state. However, 
amorphous pharmaceuticals are usually stored below the glass transition temperature. 
Thus, evaluation of such correlations in the glassy state is of immense practical value. 
The extremely long time scale of these motions and the non-ergodic nature of glasses, 
pose a challenge in experimentally characterizing the structural relaxation. The work in 
Chapter 2 was aimed at using time domain dielectric spectroscopy to comprehensively 
characterize both the time and temperature dependence of structural relaxation in the 
glassy state. Nifedipine (NIF), an antihypertensive, was used as a model compound in 
this study. Time - aging time and time - temperature superposition principle enabled us to 
calculate the time and temperature dependence of relaxation time. To the best of our 
knowledge, this is the first comprehensive investigation of structural relaxation behavior 
in a pharmaceutical glass.  
In Chapter 3, the correlation between molecular mobility and physical stability in the 
glassy state was investigated. The molecular mobility (both global and local) in the model 
systems (celecoxib and indomethacin) was comprehensively characterized using a 
combination of time and frequency domain dielectric spectroscopy. In both the 
compounds, in the supercooled state, a coupling coefficient of ~0.8 between structural 
relaxation time and crystallization time was obtained. The crystallization kinetics in the 
glassy state was monitored using synchrotron radiation. Interestingly in the glassy state, 
the βJG relaxation was better coupled to the crystallization time (coupling coefficient - 
celecoxib: 1.4 and indomethacin: 1.1).  On the other hand, no correlation was observed 
between structural relaxation and physical stability in the glassy state.  
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Chapter 4 was aimed at characterizing the structural relaxation in glassy dispersions of 
nifedipine with each poly(vinyl) pyrrolidone (PVP) and hydroxypropyl methylcellulose 
acetate succinate (HPMCAS) with the goal of understanding the effect of type of polymer 
and polymer concentration on physical stability. For pure NIF as well as the dispersions, 
the validity of the time-temperature superposition principle was established. This enabled 
the calculation of the long relaxation times in these systems. The strength of hydrogen 
bonding, structural relaxation time and crystallization followed the order: NIF-PVP > 
NIF-HPMCAS > NIF. With an increase in polymer concentration, the relaxation times 
were longer indicating a decrease in molecular mobility. This is the first application of 
the superposition principle to characterize structural relaxation in glassy pharmaceutical 
dispersions. 
Amorphous systems are typically characterized by a pronounced tendency to sorb water. 
This can potentially increase their physicochemical instability. In Chapter 5, we 
systematically varied the water content in model systems to determine the effects on (i) 
molecular mobility, and (ii) crystallization behavior. These investigations were conducted 
using nifedipine - polyvinylpyrrolidone vinyl acetate 64 (NIF - PVP) as a model solid 
dispersion and griseofulvin as a model drug substance. The observed increase in mobility 
and the decrease in crystallization onset temperature brought about by water could be 
explained by the “plasticization” effect of water. Similar results were observed in the 
glassy drug substance. A single linear relationship was observed between crystallization 
time and Tg/T in both dry and water containing systems. Since fragility is unaffected by 
modest amounts of water, much like crystallization time, the mobility in the glass is 
expected to scale with Tg. 
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One of the major challenges in the development of amorphous formulations is the reliable 
prediction of long term physical stability. Studying degradation kinetics at elevated 
temperatures and extrapolating to room temperature, an approach classically used for 
predicting chemical degradation, cannot be used for physical stability (crystallization) 
prediction. In Chapter 6, we are proposing the use of “water sorption” as an accelerated 
stability approach to predict crystallization in “dry” slow crystallizing systems (high 
polymer loading dispersions). Felodipine - PVP (FEL - PVP) dispersion was used as the 
model system. Similar to our earlier results in NIF - PVP system, both the increase in 
molecular mobility and a faster crystallization onset could be explained by the 
plasticization effect. The manifestation of this effect - a similar coupling coefficient, as in 
dry systems, was observed between molecular mobility and crystallization time in 
presence of water. Based on these findings, we are proposing the use of “water sorption” 
to build predictive models for crystallization in slow crystallizing drug dispersions.  
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8 Future work 
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Both the time and temperature dependence of structural relaxation was characterized 
using dielectric spectroscopy (Chapter 2). The structural relaxation behavior in the glassy 
state can be modeled using the Tool-Narayanaswamy-Moynihan (TNM) framework. This 
framework should then be extended to predict the structural relaxation behavior, using 
the model parameters, under any given thermal history. The predictions should be 
validated with the experimental results for several thermal histories. This would be 
valuable in determining the influence of processing and storage conditions on the 
structural relaxation behavior of amorphous pharmaceuticals. Annealing, in other words 
deliberate physical aging, has been shown to reduce the water sorption potential and 
improve the chemical stability of small molecule glasses. Physical aging studies could 
provide a mechanistic insight into this behavior and determine its correlation to properties 
of interest such as water sorption tendency and physical stability.  
In Chapter 3, molecular mobility (both global and local) was studied in model systems 
and its correlation with physical stability in the glassy state was established. Correlation 
models were successfully developed based on the coupling between local mobility (βJG 
relaxation) and stability. Validation of the developed models (for crystallization) at 
relevant temperatures would be practically valuable. Thus, the comparison of the 
predicted values (determined using the mobility values from time domain dielectric 
spectrometer) with the observed physical instability would validate the developed models 
demonstrating their practical utility. It will be useful to investigate such a correlation in a 
wide variety of glassy pharmaceuticals to draw a general conclusion. Studies determining 
the mechanism of crystallization i.e. whether it is diffusion or nucleation limited would 
be useful. The expectation is that βJG relaxation may play a dominant role in nucleation 
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limited mechanism as compared to diffusion limited. These studies also need to be 
extended to amorphous solid dispersions to identify the specific mobility mode 
responsible for physical instability. Bulk diffusion measurements, if possible, can shed 
light on the decoupling between rotational and translational motions in the glassy state. It 
would be interesting to evaluate the role of diffusion on the crystallization behavior in 
glasses.  
In Chapter 4, the effect of polymer additive/concentration on the structural relaxation 
behavior in glassy NIF dispersions was evaluated. Only the data ascribed to the structural 
relaxation, separated from the β-relaxation, was considered in the calculation. It would be 
worthwhile to tease out the contribution from the β-relaxation in order to gain a better 
understanding of the influence of polymer additive/concentration on the local mobility in 
these systems. Crystallization studies should be carried out at several temperatures in the 
glassy dispersions so to identify the specific mobility mode responsible for the observed 
physical instability. Such an approach would enhance our mechanistic understanding of 
the physical stabilization brought about by the addition of polymer in the glassy state.  
In Chapters 5 & 6, the influence of water content on the molecular mobility and 
crystallization behavior in supercooled dispersions was investigated. Our results 
demonstrate that coupling between mobility and crystallization time remains unaffected 
in presence of water. The next step would be to use the developed model to predict 
crystallization in “dry” dispersions. Once this approach is validated, then it should be 
extended to the glassy state. The influence of water on glassy state dynamics (both global 
and local) needs to be evaluated to determine a correlation with physical stability. It is 
experimentally challenging to retain water in the systems. Therefore, using a non-volatile 
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small molecule glass former such as glycerol may be more practically feasible for these 
studies.  
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